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Changes in intracellular redox homeostasis are implicated in both normal cell signaling 
and as pathophysiological mechanisms contributing to a variety of age-related diseases, 
including diabetes, atherosclerosis, neurodegenerative conditions, and cancer.  Though a 
variety of well described mechanisms exist to counterbalance the overproduction of 
cellular oxidants and maintain optimal intracellular redox poise, the understanding of the 
mechanism(s) through which cellular redox homeostasis regulates cell signaling 
functions is less well understood.  Here, we demonstrate that signaling by the immediate 
early gene / orphan nuclear hormone receptor NGFI-B (Nur77, TR3), which functions 
pleiotropically in the regulation of cell growth, metabolism, differentiation and death in 
diverse tissues, is redox-regulated at both the level of induction and NGFI-B-dependent 
gene transcription.  Using co-immunoprecipitation experiments in cells, we also 
identified a novel interaction between NGFI-B and the cytoplasmic thiol-reducing 
catalyst thioredoxin1 (Trx1), that, similar to DTT, blocks NGFI-B-dependent gene 
expression in a manner that depends on the Trx1 active site cysteines.  Together these 
observations add NGFI-B-dependent gene expression to a growing portfolio of 
transcription factor pathways that are redox-regulated.  
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 NGFI-B, in addition, appears to regulate the mitochondrial membrane potential in 
L6 skeletal myoblasts.  NGFI-B is indispensible for T-cell receptor-mediated apoptosis 
and induces cell death in a variety of cell types in response to diverse pro-apoptotic 
stimuli.  Like p53, translocation of NGFI-B from the nucleus to the mitochondria may be 
a critical aspect of its pro-apoptotic function.  Interestingly, we found that enforced 
NGFI-B expression in L6 skeletal muscle myoblasts led to a significant decrease of MMP 
that peaked 48hr after transfection and did not require a cell death-inducing stimulus.  
Moreover, NGFI-B transfected cells had no increase in mitochondrial cytochrome C 
release despite loss of MMP at 48 hr.  Combined, these data suggest that loss of MMP in 
muscle cells may be an early event in the apoptotic process regulated by NGFI-B.  This, 
along with the redox regulation of NGFI-B, provides unique evidence of a relationship 
between the mitochondria, mitochondrial by-products, ROS, and the regulation of and by 
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Chapter 1:  Introduction 
 
1.1        BACKGROUND 
Cellular reactive oxygen species including superoxide, peroxides, and hydroxyl 
radicals, have risen over the last several years from their infamous status as capricious 
toxic byproducts of aerobiosis to requisite mediators of a variety of cell fate specification 
signaling pathways (Cross, Halliwell et al. 1987).   Decades old work dealing with the 
mechanisms linking ROS generation to neurodegenerative, inflammatory, and neoplastic 
diseases has informed the more recent view that cells also intentionally produce, sense, 
and destroy oxidants as part of a novel second messenger signaling system in cells (Allen 
and Tresini 2000; Balaban, Nemoto et al. 2005; D'Autreaux and Toledano 2007; Genestra 
2007). Although the biochemical mechanisms of oxidative damage to lipids, proteins, and 
DNA in the context of high concentrations of oxidative species (e.g. “oxidative stress”) 
are well described, comparably less is known about the mechanisms and targets of 
physiological oxidative signaling.  
Pioneering work beginning in the mid 1990’s established that ROS are important 
cell growth messengers.  It was initially discovered that tyrosine kinase receptor-activated 
ROS production promotes growth factor-induced cell growth through the inactivation of 
growth inhibitory tyrosine phosphatases (Lee, Kwon et al. 1998; Rhee, Bae et al. 2000; 
Kwon, Lee et al. 2004).  Other reports demonstrated that ROS also control cell functions 
by directly modifying the activities of transcription factors; a notable example is the 
induction of antioxidant genes in response to activation of the transcription factor 
complex AP-1 (Allen and Tresini 2000).   In yeast, the orthologous Yap1 transcription 
factor was shown to rapidly redistribute to the nucleus and regulate gene expression in 
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response to the oxidation of protein disulfide bonds (Wood, Storz et al. 2004).  Since 
these initial observations, a small but growing list of redox sensitive transcription factor 
signaling networks has been identified. 
With this new evidence revealing that ROS are crucial signaling molecules more 
attention is being placed on the mitochondrial production of ROS, the major source of 
endogenous ROS within the cell.  A variety of factors exist regulating the production of 
mitochondrial ROS, including uncoupling proteins, calcium signaling and the MPTP, as 
well as nutrient sensing transduction pathways (Garlid, Jaburek et al. 2001; Halestrap, 
McStay et al. 2002; Sabatini 2006).  It is now clear that mitochondrial bioenergetics is far 
more involved in the regulation of cellular processes than simply maintaining energy 
production and crucial to further our understanding of the mechanisms by which cellular 
metabolism regulates cell fate decisions.   
The mitochondrial membrane potential (MMP) was once thought to solely 
provide the electrochemical gradient necessary for the production of ATP (Mitchell 
1979) however the MMP is now considered important for both signal transduction and 
apoptosis (Huttemann, Lee et al. 2008).  Loss of the MMP occurs when an increase in 
proton conductance thereby dissipates the difference between protons within the 
intermembrane space and those found in the mitochondrial matrix.  This depolarization of 
the MMP has been demonstrated to increase the transfer of electrons from the donors and 
acceptors of the ETC, thereby reducing the likelihood that electrons slip and create 
superoxide (Korshunov, Skulachev et al. 1997; Liu 1999).  Loss of MMP and the means 
that regulate this loss could therefore be directly involved in altering redox poise within 
the cell.  It is necessary that future redox signaling research not only continue to identify 
the downstream targets of ROS signaling, but also identify the variety of mechanisms in 
place regulating the production of the signaling molecule itself. 
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1.2         REACTIVE OXYGEN SPECIES (ROS) 
The early incorporation of the energy producing bacteria or mitochondria into a 
single cell brought with it both benefits as well as draw backs (Balaban, Nemoto et al. 
2005).  Although oxygen consumption and mitochondrial respiration are vital to an 
organism’s survival, the metabolic by-products have been shown to cause damage to the 
cell lending to the aging of an organism and several degenerative diseases.  Reactive 
oxygen species have long been regarded as destructive by-products of aerobic respiration 
capable of irreversibly damaging lipids, proteins, and DNA.  While that may still be true 
when their levels go unchecked, evidence over the past decade has shown that ROS also 
act as a second messengers capable of regulating cell function (D'Autreaux and Toledano 
2007).  It has now become more and more clear that the antioxidant system once thought 
to be our only line of defense against these damaging by-products actually acts in concert 
with oxidants to regulate a variety of cellular processes from proliferation to cell death. 
1.2.1    Types of ROS 
Oxidants or ROS are molecules or ions generated by the incomplete one electron 
reduction of oxygen.  Better known ROS include superoxide, hydrogen peroxide, 
hydroxyl radical, nitric oxide, and peroxynitrate. ROS are highly reactive because they 
carry an unpaired valence shell electron.  The reactivity of the various oxidants depends 
on their production within the cell, the presence of enzymes which regulate their 
conversion to less reactive species, and their rate of oxidation of other molecules within 






Super Oxide Anion O2 + e- → O2- • 
Hydrogen Peroxide HO2• + e- + H → H2O2 
Hydroxyl Radical H2O2  + e- → OH- + •OH 
Fenton Reaction H2O2 + Fe2+ → OH- + •OH + Fe3+
Nitric Oxide L-Arginine + O2 → 
•NO + L-
Citrulline 
Peroxynitrite O2- • +  •NO → ONOO- 
 
REACTIVITY:  O2- • < H2O2 < •OH 
DIFFUSION:  H2O2 >>> O2- • = •OH 
Table 1: Equations representing the production of endogenous reactive oxygen species. 
Superoxide is the most prevalent form of ROS and is considered the “primary” 
ROS giving rise to other forms of “secondary” ROS.  Superoxide is produced throughout 
the cell by metabolic respiration, NADPH oxidase isoforms, or by irradiation of 
molecular oxygen.  While it is the most abundant oxidant within the cell it is tightly 
regulated and quickly dismutated to hydrogen peroxide due to the presence of cytosolic 
and mitochondrial superoxide dismutases.  The rate (103 M-1s-1) at which superoxide 
could oxidize a thiol moiety is insignificant compared to the rate (> 109 M-1s-1) at which it 
is converted to hydrogen peroxide (Forman and Fridovich 1973).  No direct targets of 
superoxide have been demonstrated in vivo, however, its connection to signaling has been 
described.  It is highly likely that the signaling role of superoxide is attributed to its role 
as the precursor to hydrogen peroxide. 
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The hydroxyl radical is most notably generated from the Fenton reaction when 
hydrogen peroxide interacts with metal ions such as iron (Fe2+).  It is considered one of 
the most reactive of the oxidant species generated within the cell, with an extremely short 
half life of approximately 10-9 s (Pastor, Weinstein et al. 2000).  It shows no specificity 
and reacts with almost any biological molecule in its path.  While this makes it a poor 
second messenger, the hydroxyl radical has been implicated in some signaling pathways 
involving lipid peroxidation such as 4-hydroxy-2-nonenal and the release of isoprostanes 
(Mohler, Franklin et al. 1996; Levonen, Landar et al. 2004; Rinna and Forman 2008).  
However, these markers of ROS signaling by the hydroxyl radical are often associated 
with oxidative stress and damage and thus hydroxyl radicals are not widely considered 
physiologically relevant signaling mediators. 
Hydrogen peroxide is considered the most likely physiological form of ROS, 
aside from nitric oxide, to serve as second messenger within a signaling cascade.  As 
stated before hydrogen peroxide is most often generated from the dismutation of the 
superoxide ion.  As a result, hydrogen peroxide is regulated and limited by the same 
spatial and temporal generation of superoxide as well as the antioxidant catalase which 
converts hydrogen peroxide to water and oxygen.  Hydrogen peroxide is a non-polar 
molecule and can therefore cross membranes (Forman, Maiorino et al.).  The main means 
of protein oxidation generated by hydrogen peroxide is on specific thiols or cysteines.  
These cysteines are often referred to as reactive cysteines because of their decreased pKa 
and residence near basic amino acids that support the thiolate anion form (Barford 2004).  
Since the discovery of hydrogen peroxide-dependent thiol oxidation other amino acids 
such has methionine have also been shown to be oxidized (for extensive review see (Vogt 
1995; Hoshi and Heinemann 2001; Stadtman, Moskovitz et al. 2003). 
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Nitric oxide is the most established reactive oxygen species in cell signaling, 
winning “Molecule of the Year” in 1992 by Science Magazine.  It is produced 
endogenously by the nitric oxide synthase enzymes using NADPH, L-arginine, and 
oxygen and plays a crucial signaling role in a variety of tissues within the cell (Palmer 
and Moncada 1989).  Nitric oxide is highly reactive with a half life of only a few seconds 
and like hydrogen peroxide can diffuse freely across membranes making it an ideal 
paracrine and autocrine signaling agent (Moncada and Higgs 1991).  The involvement of 
nitric oxide signaling has been well established in vascular endothelial dilation (Ignarro, 
Cirino et al. 1999).  Similar to hydrogen peroxide nitric oxide directly modifies protein 
targets via S-nitrosylation on specific amino acids such as cysteines (Hess, Matsumoto et 
al. 2005).  This post-translational modification of target proteins has been shown to 
regulate gene expression, energy production, and a variety of other cellular processes 
(Moncada, Palmer et al. 1991).  When the production of superoxide and nitric oxide 
occur within close proximity to one another with in the cell the potent reactive oxygen 
species peroxynitrite is formed.  Like the hydroxyl radical, peroxynitrite is often 
extremely damaging and associated with oxidative stress conditions for which more 
superoxide is present within the cell.  
1.2.2    Generators of ROS 
All organisms living under aerobic conditions have several enzyme systems that 
produce reactive oxygen species, including mitochondrial, peroxisomal, oxidoreductases, 




The majority of oxidants are produced during aerobic respiration when electrons 
slip from the electron transport chain.  This process is thought to mediate the production 
of ~80-90% of all basal oxidants. Molecular oxygen is the substrate for cytochrome 
oxidase (complex IV) and the terminal acceptor of electrons that flux across the 
mitochondrial respiratory chain during oxidative phosphorylation.   However, electrons 
can also be released from ubisemiquinone binding sites in complexes I and III and non-
enzymatically reduce oxygen to generate the reactive oxidant superoxide, which is 
rapidly converted to hydrogen peroxide by the mitochondrial and cytoplasmic isoforms 
of superoxide dismutase (Mn SOD and Cu/Zn SOD, respectively).  Topologically, 
superoxide released from complex I is thought to occur mainly in the mitochondrial 
matrix, whereas complex III-generates superoxide in the mitochondrial intermembrane 
space (St-Pierre, Buckingham et al. 2002).  Evidence also suggests respiratory complex 
II, glycerol-1-phosphate dehydrogenase, and dihydroorotate dehydrogenase may also 
contribute to the production of mitochondrial ROS (Krungkrai 1991; McLennan and 
Degli Esposti 2000; Lenaz 2001).   While the production of ROS by the mitochondria and 
the part these metabolic by-products play in damaging the cell has been established, the 
exact role mitochondria ROS plays in signal transduction remains unclear. 
 
1.2.2.2 Other generators of endogenous ROS 
Other sources of endogenous ROS production include the nicotinamide adenine 
dinucleotide phosphate (NADPH)-dependent enzymes, the xanthine oxidoreductase 
(XOR), which is involved in purine catabolism, and the organelle known as the 
peroxisome.  These oxidant producing enzymes and organelles are located in the majority 
of cell types within an organism but serve a wide variety of cell-type specific functions. 
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The NADPH-dependent enzymes include the family of NADPH oxidases 
(NOX1-4), as well as the members of the nitric oxide synthase (nNOS, eNOS, and iNOS) 
family. The NOX family of enzymes was originally discovered for their role in 
phagocytic cells and the creation of superoxide for the defense against foreign organisms. 
It was not until their discovery in non-phagocytic tissues such as bovine arterial smooth 
muscle, myocytes, and endothelium (Mohazzab, Kaminski et al. 1994) that researchers 
began to describe a role for these enzymes in redox-signaling cascades.  While 
superoxide remains a fairly poor second messenger, the time and spatial release 
associated with the NOX enzymes makes them excellent generators of ROS for cell 
signaling.  NOX-generated superoxide has been implicated in the ROS bursts associated 
with growth factors such as platelet derived growth factor (PDGF) and transforming 
growth factor β (TGFβ) induced protein tyrosine phosphorylation cascades (Abid, Kachra 
et al. 2000; Hu, Ramachandrarao et al. 2005).  The mechanism by which the NOX family 
produces superoxide involves a small Rho guanosine triphosphatase (GTPase), usually 
Rac1 or Rac2, assembling with five phagocytic oxidase subunits which utilize electrons 
from NADPH to produce the free radical superoxide: NADPH + 2O2 ↔ NADP+ + 2O2°- 
+ H+ (reviewed extensively in Morel, Doussiere et al. 1991; Groemping and Rittinger 
2005; Ushio-Fukai 2006; Bedard and Krause 2007). Superoxide is then dismutated 
further by a superoxide dismutase to the more oxidizing redox second messenger 
hydrogen peroxide (H2O2).  The time and spatial regulation of the NOX-dependent 
production of superoxide depends on both the assembly of the subunits (NOX1,2) or the 
transcription of the oxidase itself (as for NOX4) as well as their location within the cell 
(Thannickal and Fanburg 2000).  NOX enzymes have now been described at the plasma 
membrane of cells as well as within the nucleus and at the endoplasmic reticulum (Ushio-
Fukai 2006).   
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Nitric Oxide synthase, which is involved in a wide variety of cell signaling 
pathways, converts L-arginine and NADPH to nitric oxide and L-citrulline.  There are 
three known NOS family members: neuronal nNOS (NOS-1), cytokine inducible iNOS 
(NOS-2) and endothelial eNOS (NOS-3).  The eNOS is anchored to the plasma 
membrane of endothelial cells and has primarily been characterized for its role in the 
production of nitric oxide for vasodilation of blood vessels.  Mutations and deletions of 
eNOS result in disorders such as atherosclerosis and erectile dysfunction (Hurt, Musicki 
et al. 2002; Musicki, Kramer et al. 2005; Yang and Ming 2006).  The nNOS synthase is 
found in the cytosol of neuronal and skeletal muscle tissue and primarily functions in cell 
to cell communication while the iNOS is located in macrophages and within the 
cardiovascular system where cytokines and other inflammatory signals induce iNOS-
dependent production of nitric oxide to defend against foreign pathogens (Sessa 1994).  
Researchers have shown that the NOS family can produce superoxide especially when 
lacking the substrate L-arginine (Xia, Dawson et al. 1996).  The fact many NOS enzymes 
are localized near SOD enzymes and xanthine oxidases, as well as the inhibitory effect 
superoxide has been shown to have on nitric oxide production suggests the propensity for 
all ROS signaling to be co-dependent and tightly regulated by one another. 
The xanthine oxidoreductase (XOR), first discovered as generator of endogenous 
superoxide in 1968 by McCord and Fridovich (McCord and Fridovich 1968), is made up 
of two forms of the same enzyme identified as xanthine oxidase and xanthine 
dehydrogenase.  During purine degradation the oxidase form of the XOR enzyme 
produces both superoxide and nitric oxide species while the dehydrogenase form 
produces the potent antioxidant, uric acid (Hille and Nishino 1995).  The XOR has 
therefore been considered a significant regulator of intracellular redox homeostasis and is 
widely used as generator of superoxide for in vitro experimentation (Afanas'ev 2005). 
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Peroxisomes are eukaryotic organelles responsible for both β-oxidation of lipids 
and the removal of damaged or obsolete proteins from the cytosol (Brown and Baker 
2008). The peroxisomal fatty acyl-CoA oxidizing system utilizes oxygen and NAD as 
electron acceptors, but differs from mitochondrial β-oxidation by virtue of the reduction 
of molecular oxygen.  Rather than creating superoxide or water, acyl-CoA oxidase 
transfers its electrons to oxygen, producing both trans-2-hexadecenoyl-CoA and  
hydrogen peroxide from palmitoyl-CoA (Osumi and Hashimoto 1978), similar to what 
has been observed for glyoxysomes, an organelle found in plants (Lazarow and De Duve 
1976).  To prevent the toxic build-up of hydrogen peroxide, peroxisomes contain high 
levels of the antioxidant enzyme catalase (Olsen 1998).  Under normal physiological 
conditions the levels of hydrogen peroxide within the peroxisomes are minimized to 
prevent release into the cytosol.  It is only when damaged or the amount of peroxisomal 
catalase is disrupted that hydrogen peroxide is released into the cytosol, causing oxidative 
stress and a variety of metabolic and neurological disorders (Sheikh, Pahan et al. 1998). 
1.2.3    Antioxidants/enzymatic regulation 
 To maintain redox homeostasis and defend against the damaging aspects of ROS, 
a variety of enzymes exist to counteract the effects of ROS within the cell.  To convert 
superoxide to the less reactive and more viable signaling molecule hydrogen peroxide 
two superoxide dismutase enzymes exist in mammalian cells, the cytoplasmic 
copper/zinc superoxide dismutase (Cu,Zn SOD) and the mitochondrial manganese 
superoxide dismutase (MnSOD).  It is reasoned that mitochondria contain their own SOD 
because a significant amount of ROS production is associated with metabolic respiration 
(Paul, Belton et al. 2007).  Further conversion of hydrogen peroxide to water and oxygen 
is mediated by the endogenous enzymes catalase.  A variety of other molecules such as 
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ascorbic acid (Vitamin C), melatonin, uric acid, and tocopherols (Vitamin E) react non-
enzymatically with ROS and thereby work in concert with other antioxidant enzymes to 
remove ROS as well as ROS-damaged substrates, such as oxidized lipids found 
throughout the cell (Cadenas 1997).   
 The antioxidant enzyme families, including systems, thioredoxins/thioredoxin 
reductase, peroxidases/sulfiredoxins, and the glutathione system (including the peptide 
glutathione/glutathione peroxidases/glutathione reductase/glutathione S-transferase) also 
are crucial for regulation of intracellular redox homeostasis.  These enzyme systems 
function in pairs due to the mechanism by which they interact and regulate protein 
oxidation throughout the cell.  This mechanism involves one or two reactive cysteines 
located within an active site that can interact with an oxidized protein thereby reducing 
that protein’s thiols back to their sulfhydryl state (Holmgren 1995; Rhee, Kang et al. 
1999). More specifically, the NH3-terminal active site cysteine residue has a low pKa 
value and can therefore mediate a nucleophilic attack of the target disulfide to form a 
covalent mixed disulfide intermediate.  This action is immediately followed by further 
reduction executed by the COOH-terminal active site thiolate, now deprotonated leaving 
a reduced target protein and active site disulfide in a thiol reducing enzyme such as 
thioredoxin (Berndt, Lillig et al. 2007). This sulfenic acid or disulfide is then reduced by 
the corresponding reductase partners, such as thioredoxin reductase using electrons from 
NADPH to continue functioning as reducing catalysts (Mustacich and Powis 2000).  
Overexpression of one or more of these antioxidants has been shown to prolong life span 
in several animal species from C. elegans (Fierro-Gonzalez, Gonzalez-Barrios et al.; Jee, 
Vanoaica et al. 2005; Olahova, Taylor et al. 2008) to mice (Weisbrot-Lefkowitz, Reuhl et 
al. 1998; Mitsui, Hamuro et al. 2002) further linking redox homeostasis to the aging 
process.  Similarly, loss or mutation of one or more of these antioxidants often results in 
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heightened susceptibility to ROS-related disease states and aging (Kang, Rhee et al. 
2005; Ballatori, Krance et al. 2009). 
 
1.2.4    ROS-related disease states and ageing 
1.2.4.1 ROS-related disease states 
 An increase in ROS has been implicated in a wide variety of pathological 
processes and can be sub-divided into two different categories.  The first group is 
characterized by a shift towards oxidative stress and imbalance of the thiol/disulfide 
redox state of the cell, often resulting in damaged glucose tolerance leading to diabetes 
mellitus, carcinogenesis and a variety of neurological disorders (Ceriello and Motz 2004; 
Klaunig and Kamendulis 2004).  It is believed that several oxidant generators including 
the mitochondria, NOX enzymes, and lipoxygenase produce ROS in response to 
hyperglycemic conditions associated with Type II diabetes (Brash 1999; Nishikawa, 
Edelstein et al. 2000; Li and Shah 2003).  While ROS are not considered the outright 
cause of diabetes mellitus, its chronic production is thought to be involved in the 
consequences associated with diabetes, such as cardiovascular disease and retinopathy 
(Brownlee and Cerami 1981).  Notably however, studies have also revealed that β-cells 
within the pancreatic islets have extremely low levels of antioxidant enzymes and this 
along with direct evidence in rats exhibiting β-cell vulnerability to hydrogen peroxide 
indicate these critical insulin producing cells are extremely prone to oxidative damage 
(Malaisse, Malaisse-Lagae et al. 1982).  Antioxidant treatments demonstrate anti-
apoptotic effects in β-cells and have exhibited beneficial effects in patients diagnosed 
with Type II diabetes by preserving the functioning β-cells left.  More understanding, 
however, of the connection of ROS and the onset and progression of diabetes is needed. 
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 While the link of ROS to carcinogenesis is well established the numerous roles 
ROS can play in tumor development and metastasis make it difficult to fully comprehend 
their mechanisms of action in every type of cancer.  The major function attributed to ROS 
in the development of cancer is a result of the creation of DNA oxidative damage, leading 
to constitutive activation in proto-oncogenes such as c-Myc (Vafa, Wade et al. 2002) and 
Ras (Li, Firozi et al. 2002) as well as mutations in the tumor suppressor genes p53 
(Hollstein, Sidransky et al. 1991) and P16INK4a (Hiroyasu, Ozeki et al. 2002) resulting in 
the loss of crucial cell cycle and DNA repair proteins and promotion of uncontrollable 
cell growth.  While this initiation role of ROS in carcinogenesis remains true, the 
establishment of ROS as a signaling agent suggests aberrant ROS signaling cascades can 
also lead to alterations in normal regulatory processes and activation of transcription 
factors, such as AP-1 and NFκB, often leading to rampant cell growth (Klaunig and 
Kamendulis 2004).  Disruptive ROS signaling, whether because of an increase in ROS 
production or a decrease in antioxidant enzymes, has been now been clearly 
demonstrated to play a role in carcinogenesis.  It has been shown to lead to the 
upregulation of cellular processes such as angiogenesis which is considered a hallmark 
for tumor survival as well as the upregulation of certain genes such as those involved in 
mitochondrial biogenesis and glucose metabolism (Valko, Leibfritz et al. 2007).  
 ROS have also been implicated in several degenerative neurological disorders 
such as Alzheimer’s and Parkinson’s disease.  As a result of the brain’s high oxygen 
consumption and high concentrations of metal ions (Fe, Cu), it is considered extremely 
susceptible to oxidative damage over an individual’s lifespan (Valko, Leibfritz et al. 
2007).  Mounting evidence suggests a direct relationship between oxidative stress and the 
development of Alzheimer’s disease.  Alzheimer patients display extensive oxidative 
damage in the form of lipid peroxidation (e.g. 4-hydroxynonenal), an increase in DNA 
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and protein oxidation including the crucial lipid transporter, apolipoprotein E (apoE), and 
an increase the damaging free radicals peroxynitrite and the hydroxyl radical (Butterfield, 
Castegna et al. 2002).  Increased production of ROS has also been implicated in 
Parkinson’s disease.  Here abnormally functioning mitochondria, along with the presence 
of ferrous ions and superoxide lead to the oxidation of dopamine and production of the 
neurotoxic compound 6-hydroxydopamine.  The presence of high amounts of 6-
hydroxydopamine leads to the death of dopaminergic neurons within the midbrain and is 
considered a marker of Parkinson’s disease (Jenner 2003).  Similar to diabetes and 
carcinogenesis, it is difficult to separate and therefore study whether the role of ROS in 
these nueropathologies is the primary cause or a secondary consequence of other aberrant 
pathways already set in motion.  The thiol antioxidants glutathione (GSH), N-acetyl-
cysteine (NAC), and dithiothreitol (DTT), however, have been shown to protect 
dopaminergic neurons from dopamine autooxidation and apoptosis (Offen, Ziv et al. 
1996) associated with Parkinson’s disease suggesting modulation of redox poise could be 
a viable treatment option. 
The second group of ROS-related diseases encapsulates other pro-oxidant 
inflammatory conditions and is characterized by an increase in ROS produced by the 
NOX family of enzymes as well as the XOR enzyme.  These inflammatory oxidative 
conditions include atherosclerosis, ischemic/reperfusion injuries, and rheumatoid 
arthritis.  An increase in ROS has been established to promote angiogenesis involved in 
the formation of atherosclerotic legions (Khatri, Johnson et al. 2004).  This results from a 
variety of ROS-related effects such as oxidation of lipids, stimulation of VSMC 
proliferation and migration, and expression of adhesion molecules.  The production of 
ROS involved in atherosclerosis primarily comes from the NOX family members found 
in the macrophages.  These macrophages localize to inflamed regions within the blood 
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vessel, begin to accumulate low density lipids (LDL), and transform into adhesive foam 
cells that accumulate and obstruct the vessel (Ross 1999).  The oxidation of LDL signals 
for further inflammation and compounds the injury.  Antioxidant treatment has at times 
proven difficult possibly because of this overwhelming oxidative feedback loop, 
however, studies using the antioxidants probucol, a-tocopherol, and ascorbate have 
exhibited inhibition of atherosclerosis progression in animal models (Jialal and Devaraj 
1996). 
ROS generation resulting from ischemia/reperfusion injuries create serious 
complications for stroke victims and recipients of organ transplantation.  During ischemia 
the XOR enzyme is primarily operating in its oxidase form.  Once reperfusion finally 
occurs hypoxanthine and xanthine purine products that have accumulated are metabolized 
by the xanthine oxidase thereby generating massive amounts of superoxide and hydrogen 
peroxide (Granger, Stokes et al. 2001).  This sudden and enormous amount of ROS 
production causes severe oxidative damage often signaling nearby cells to undergo 
apoptosis. 
Chronic inflammation and oxidative injury are also associated with rheumatoid 
arthritis.  This autoimmune disorder results in the accumulation of monocytes and 
lymphocytes within the synovial fluid.  Once there the release of free radicals by the 
gathered phagocytes results in direct or indirect oxidative damage of nearby cartilage and 
extracellular matrix, as well as further aberrant ROS signaling, resulting in apoptosis or 
activation of metalloproteinases (Maurice, Nakamura et al. 1997).  The synovial joints, 
like β-cells, contain low levels of the antioxidant SOD making them more vulnerable to 
oxidative damage (Mazzetti, Grigolo et al. 1996).  Vitamin E has been demonstrated to 
reduce joint inflammation in transgenic KRN/NOD mouse model of rheumatoid arthritis 
(De Bandt, Grossin et al. 2002).  The use of a superoxide dismutase mimetic (M40403) 
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also demonstrated relief of arthritic symptoms in a rat model of collagen induced arthritis 
(Salvemini, Mazzon et al. 2001) once again supporting a link between ROS and this 
disease state and providing viable treatment options. 
 
1.2.4.2 ROS and the ageing process 
Research utilizing the animal model Caenorhabditis elegans (C. elegans) has 
demonstrated that mutations in pathways which regulate oxidative stress often have an 
enormous impact on lifespan (Finkel, Serrano et al. 2007).  In 1965, Denham Harman 
proposed the free radical theory of ageing (Harman 1956) stating the gradual decline in 
physiological function or ageing is the result of the accumulation of free radicals 
produced by metabolic respiration and the cumulative damage they do to DNA, lipids, 
and proteins within an organism over time (Hayflick 1998).  This theory, along with 
others that have stemmed from it, is based on the fact that oxygen is a necessary evil in 
the survival of an organism (Balaban, Nemoto et al. 2005).  A lack of oxygen would 
cause a halt to oxidative phosphorylation, a reduction in ATP, and cell death.  During the 
process of aerobic metabolism in mitochondria, oxygen functions as a recipient of 
electrons that flux across the respiratory chain of redox donors and acceptors.  Electrons, 
however, are prone to leaking even in healthy organisms (Hanukoglu, Rapoport et al. 
1993; Salvador, Sousa et al. 2001).  These electrons slip to molecular oxygen and 
generate the free radical/oxygen derivative superoxide.  Approximate 1-3% of all 
molecular oxygen within the mitochondria of even healthy organisms is converted to 
superoxide (Benzi, Pastoris et al. 1992; Kinnula, Crapo et al. 1995).  Many  believe that 
while superoxide and other ROS can indiscriminately damage any macro-molecule in 
their proximity, it is the accumulation of superoxide-damaged mitochondrial DNA 
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(mtDNA) that eventually causes the  mitochondria to shut down, energy production to 
cease, and the triggering of cell death that lead an organism to age (Cadenas and Davies 
2000).    A study of a mouse model containing a defective mitochondrial proof-reading 
polymerase resulted in an increase in mtDNA point mutations followed by the onset of a 
variety of age-related characteristics such as hair-loss, decreased fertility, and finally an 
overall decrease in lifespan compared to wild type (Trifunovic, Wredenberg et al. 2004).  
This evidence along with the confirmed role ROS plays in DNA damage places ROS as a 
major player the process of aging. 
Studies on energy expenditure and lifespan in flies and worms reveal an inverse 
relationship between aerobic respiration/oxygen consumption and the lifespan of an 
organism (King and Barnett 1995; Gems and Doonan 2009). Also, an organism’s rate of 
ROS production along with how effective its antioxidant defense system is has a dramatic 
impact on lifespan.  Interestingly one of the most well known and controversial examples 
of the inverse relationship between oxygen consumption and lifespan in mammalian 
models, such as mice and rats, is the extended lifespan produced by caloric restriction.  
By reducing caloric intake, by approximately 30%, studies have shown a reduction in the 
generation of ROS and ROS-related DNA damage biomarkers such as 8-hydroxy-2'-
deoxyguanosine (8-OH-dG) (Richter 1988; Barnett and King 1995).  This reduction in 
both nuclear and mitochondrial DNA damage is believed to be directly related to the 
extension of lifespan and has since been adapted by some humans as a strategy to prolong 
life.  Scientists are currently trying to uncover the regulatory pathways involved in the 
pronounced effect of caloric restriction on lifespan.  One promising area of research 
involves the target of rapamycin (TOR) signaling pathway (for extensive review see 
(Sabatini 2006; Wullschleger, Loewith et al. 2006).  The TOR signaling cascade has been 
established to regulate a variety of cell pathways in response to nutrient levels within the 
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cell.  It is active when nutrient levels are high and promotes cell growth, and is inactive 
during periods of starvation.  Many of the proteins involved in the TOR signaling 
pathway, such as PTEN, also represent well established targets of ROS signaling 
suggesting a potential cross talk between these two pathways.   
Other research has uncovered an alternate theory by virtue of the function 
attributed to the uncoupling protein (UCP) family. UCPs have been shown upon 
activation to provide a pore within the ETC that allows protons to reenter the matrix from 
the intermembrane space.  This not only lowers mitochondrial membrane potential and 
reduces the production of ATP by Complex V, but it is thought this also allows electrons 
to flux more efficiently across the ETC, thereby lowering electron slippage to oxygen and 
reducing ROS production (Korshunov, Skulachev et al. 1997; Liu 1999).  The 
“uncoupling to survive” hypothesis therefore suggests the regulation of metabolic ROS 
production could be a built in mechanism for maintaining the same rate of oxygen 
consumption while uncoupling it from ATP production, thereby lowering the generation 
of ROS and preventing further damage to the cell (Brand 2000; Balaban, Nemoto et al. 
2005).  Studies in out bred mice revealed that those with the highest metabolic rates 
displayed longer life spans than mice with low metabolic rates.  Mitochondria isolated 
from these mice revealed those with higher metabolic rates also exhibited and increase in 
proton conductance attributed to an increase in the activation of proton leaks through the 
adenine nucleotide transporter (ANT) and uncoupling protein 3 (UCP3) (Speakman, 
Talbot et al. 2004).  The mechanism by which UCPs create a proton leak remains 
unknown and researchers are currently attempting to understand how these unique proton 
channels are involved in the regulation of redox homeostasis, metabolism, and overall 
cell fate decisions.  It is not likely that ROS-related damage alone is responsible for the 
aging process, but rather the gradual malfunction and destabilization of a variety of 
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pathways within the cell and the mechanisms by which they communicate and regulate 
one another. 
1.2.5   ROS-signaling 
 Emerging evidence implicates ROS as important mediators of signal transduction 
cascades involved in the regulation of cell fate.  In order for a molecule to be considered a 
second messenger or signaling molecule, it must fall into four categories (Hancock, 
Desikan et al. 2001).  First it must show substrate specificity and not indiscriminately 
modify anything in its path.  While all ROS share the ability to react and damage DNA, 
proteins, and lipids within the cell, only hydrogen peroxide is thought to show the 
specificity necessary to be a suitable second messenger.  The predominant target of direct 
oxidation by hydrogen peroxide is protein thiols, commonly referred to as reactive 
cysteines found in certain proteins within the cell.  
The second criteria requires that the modification must be reversible, similar to an 
on and off switch.  Proteins containing oxidized disulfide bridges or hydroxylated 
cysteines can be reduced back to sulfhydryl groups by antioxidant enzymes such as 
glutathione or thioredoxin.   
Third, there must be some means of temporal regulation.  The induction of the 
second messenger, in this case ROS, must be activated and operate according to 
physiological time scales.  This includes the mitochondria and other oxidant generating 
systems.  It is well established that several extracellular stimuli such as growth factors 
and cytokines as well as mitochondrial inhibitors and substrates can increase the 
production of ROS within the cell (Martindale and Holbrook 2002).  The location of 
these oxidant generating enzymes and mitochondria as well as the cells ability to react to 
ROS inducing stimuli allow for the presence of ROS to be both spatial and temporal 
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thereby only being able to regulate signaling cascades at certain times and in certain 
places within the cell.   
Lastly, there must be a system of enzymes capable of regulating the presence of 
the second messenger to prevent irreversible and unchecked alterations.  This includes 
the well known antioxidant enzymes catalase and SODs as well as the antioxidant protein 
systems such as thioredoxin/thioredoxin reductase and glutathione/glutathione reductase 
which are capable of converting oxidized proteins back to their reduced states. 
 
Cell Compartment Biochemical Events Cell response 
Plasma Membrane 
/Cytosol 
Inhibition of phosphatases; 
Activation of kinases: ERK, JNKs, p38, 








Impaired DNA binding of AP-1, NF-
кB, p53, and the Glucocorticoid 
receptor  
Growth arrest 




Mitochondrial damage activation of 
NF-кB and JNK-1 
Hypoxic response 







Table 2: Established ROS-signaling mechanisms in subcellular compartments  
1.2.5.1 Mechanisms of redox regulation 
One mechanism for direct regulation of a protein by ROS-signaling is through the 
oxidation of cysteine thiols.  This either results in the creation of a disulfide bridge or a 
hydroxylated cysteine (S-hydroxylation) residue, both of which can be reduced back to 
sulfhydryls by the reducing catalysts thioredoxin or glutaredoxin.  The acid constant 
(pKa) of most sulfhydryl groups is approximately 8.5-10, making them less vulnerable to 
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oxidation by hydrogen peroxide (Benesch, Lardy et al. 1955).  In order for a cysteine to 
be considered oxidant sensitive, it must exist as a thiolate anion at a neutral pH (pH 7) 
(Filomeni, Rotilio et al. 2005).  The presence of nearby basic amino acids, such as 
histidine, lysine, and arginine support this anion, allowing it to have a lowered pKa at a 
neutral pH (Copley, Novak et al. 2004).  This is how most catalytic triads within the 
active sites of peroxidases and phosphatases work, and both of these enzyme families 
have been shown to have reactive cysteines prone to oxidation (Caselli, Marzocchini et 
al. 1998; Lee, Yang et al. 2002; Yang, Kang et al. 2002; Rhee, Kang et al. 2005).  It is 
also possible for cysteines to become glutathiolated (S-glutathionylation).  Glutathiolated 
proteins are present in minimal numbers under normal redox conditions, however their 
numbers increase significantly under oxidative stress conditions (Netto, de Oliveira et al. 
2007).  S-glutathionylation has hence been considered a protective modification in the 
presence of oxidative stress to prevent irreversible oxidation of cysteines to sulfinic (-
SO2H) and sulfonic acids (SO3H) (Thomas, Poland et al. 1995).  Likewise, it has also 
been well established that cysteines can be nitrosylated (S-nitrosylation) as a means of 
regulating cell function in response to nitric oxide signaling (Moncada and Palmer 1991; 
Hess, Matsumoto et al. 2005).  The amino acid methionine also possesses a sulphur-
containing side-chain susceptible to reversible hydroxylation important for signal 




Illustration 1: Redox modifications of reactive cysteines 
A reactive cysteine can exist as thiolate anion, under physiological pH.  This allows them 
to more easily undergo reversible oxidation by either reaction with ROS (S-
hydroxylation) or with the nitric oxide radical (S-nitrosylation).  Reactive cysteines can 
also react with GSSG (S-glutathiolation). This last modification has been suggested to be 
a protective action by GSH to prevent the enzyme from further oxidations, which can 
lead to irreversible oxidation and protein damage.  The thiol reducing enzymes 
thioredoxin and glutaredoxin bind to the oxidized cysteines and convert them back to 




Proteins containing iron-sulfur centers can also be subject to redox regulation.  
Research demonstrates that either direct contact with superoxide or hydrogen peroxide or 
another oxidized substrate results in the release of free ferrous from the [4Fe-4S]2+ cluster 
often acting as an off switch rendering those proteins inactive (Ramsay, Dreyer et al. 
1981).  This modification, however, is reversible and once the protein is no longer in 
close proximity with ROS the free ferrous group returns and the protein resumes its prior 
state of activity.   
 
1.2.5.2 Downstream Targets 
Not surprising given their reactivity and short half lives, one barrier towards 
understanding the functional roles of oxidants in cellular physiology is the identification 
of specific protein targets of oxidation in vivo (Janssen-Heininger, Mossman et al. 2008).  
Recent studies have successfully identified several cell signaling mediators sensitive to 
redox-regulation.  As mentioned before, several phosphatases such as PTEN and protein 
tyrosine phosphatase (PTP) include a reactive cysteine in their active site that regulates 
their activity in response to mitogenic oxidant bursts (Lee, Kwon et al. 1998; Lee, Yang 
et al. 2002; Kwon, Lee et al. 2004). Mitogenic ROS bursts are therefore believed to 
activate mitogen-activated protein kinases (MAPKs) signaling pathways via the 
inhibition of phosphatases, thereby propagating phosphorylation cascades leading to the 
upregulation of genes involved in proliferation (Kolluri, Bruey-Sedano et al. 2003).  
Studies have also shown that a disturbance in the redox balance towards oxidative stress 
allows for the activation of stress-response kinases such as certain JNK isoforms that can 
then activate the transcription of antioxidant genes necessary to restore redox 
homeostasis (Han, Cao et al. 2006).   
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Thioredoxin and the peroxiredoxin family members represent antioxidant 
enzymes that contain either a redox-active dithiol or a reactive cysteine in their active 
sites. The 12 kDa thioredoxin is highly conserved from prokaryotes to eukaryotes and 
uses Cys32 and Cys35 within its active site to undergo reversible oxidation-reduction 
reactions (Holmgren 1985; Holmgren 1995; Nishiyama, Masutani et al. 2001).  These 
redox active disulfide bridges allow thioredoxin to not only scavenger for free radicals 
but also bind and reduce a wide variety of oxidized proteins including the mammalian 
peroxiredoxins (Rhee, Kang et al. 1999).  The ubiquitously expressed thioredoxin is a 
potent reducing catalyst vital to the maintenance of redox-homeostasis and the regulation 
of ROS-signaling. 
A variety of transcription factors have also been shown to be direct targets of 
ROS signaling.  OxyR in E. coli and Yap1 in yeast represent the prototypic oxidant 
sensing transcription factors.  Each contains disulfide bonds that act as on/off switches, 
triggering the regulation of gene expression in response to oxidative stress (Zheng, 
Aslund et al. 1998; Wood, Storz et al. 2004).    On the other hand, cysteine oxidation of 
the transcription factors p53, the p50 and p65 subunits of NFΚB and the c-Jun member of 
the AP-1 complex inhibits their ability to bind DNA and regulate gene transcription.  In 
addition, the thiol reducing enzyme, thioredoxin 1 (Trx1) was found to increase p53-
dependent transcription (Jayaraman, Murthy et al. 1997), to stimulate AP-1-driven 
transcription and DNA binding by forming a complex with directly oxidized Ref-1 
(Hirota, Matsui et al. 1997), and to increase NF-κB-dependent transcription via reduction 
of the p50 subunit of NF-κB (Qin, Clore et al. 1995).  Likewise, the ability of the 
glucocorticoid (GC) receptor, a transcription factor and closely related family member to 
NGFI-B, to bind to DNA and promote transcription is inhibited in the presence of ROS 
bursts and has been shown to directly interact with Trx1, implying that it is directly 
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oxidized.  Hypoxia inducible factor 1 alpha (Hif1α) has also been shown to be directly 
nitrosylated (Sumbayev, Budde et al. 2003) and it is well-established that ROS stabilizes 
HIF1alpha under normoxic conditions (Metzen, Zhou et al. 2003). 
Lastly there are also proteins, such as the mitochondrial enzyme aconitase, that 
contain iron/sulphur ([4Fe-4S]2+) centers capable of redox regulation.  In the presence of 
superoxide or hydrogen peroxide, the aconitase enzyme is rendered inactive as a result of 
the release of Fe-α in the ferrous oxidation state leaving  aconitase with a [3Fe-4S]1+ 
cluster (Ramsay, Dreyer et al. 1981).  By virtue of the role mitochondrial aconitase plays 
in the conversion of citrate to isocitrate, it is thought by some that this process is an 
indicator of metabolic pathology and oxidative stress.  However, because of the 
reversibility of this inactivation many now consider aconitase to be a potent redox 
regulator involved in a negative feedback loop (Bulteau, Ikeda-Saito et al. 2003).  ROS 
inactivation of mitochondrial aconitase signals to slow the production of substrates for 
the electron transport chain thereby lowering the amount of mitochondrial ROS being 
produced.  Once redox homeostasis has been resolved and the excess ROS has been 
cleared studies have demonstrated the free ferrous group returns to the aconitase enzyme 
thereby allowing it to resume its normal enzyme activity within the Krebs cycle (Ramsay, 
Dreyer et al. 1981). 
 
1.3 NGFI-B 
The immediate early gene-encoded orphan nuclear hormone receptor subfamily 4, 
group A, member 1, NR4A1 (NGFI-B / Nur77 / TR3) has pleiotropic functions in cell 
growth, metabolism, differentiation and death.  Interestingly, NGFI-B is both induced 
and activated by stimuli / conditions that are highly coincident with increased ROS 
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production, including inflammation, ischemia, mitogenic growth factors, and fatty acid 
oxidation (Cheng, Volkers et al.; Zhao, Howatt et al.; Wu, Liu et al. 2002; Pei, Castrillo 
et al. 2005; Mullican, Zhang et al. 2007). 
 
1.3.1    Nuclear Hormone Receptor Superfamily 
Nuclear hormone receptors (NHRs) are a superfamily of structurally related 
transcription factors containing a highly conserved zinc-finger DNA binding domain 
(DBD) and less conserved ligand-binding domain (LBD), and a varying activation 
domain (AF).  NHR involvement in the regulation of a variety of cell functions has been 
well described (Mangelsdorf, Thummel et al. 1995; Ribeiro, Kushner et al. 1995; Kumar 




















































 Ann Rev M


















NHRs were named for both their ability to bind the diverse hormones within the body as 
well as their prominent localization within the nucleus.  The NHR family includes the 
better known estrogen receptor (ER), glucocorticoid (GC) receptor, the retinoic acid 
receptor (RAR), retinoid X receptor (RXR), and the liver X receptor (LXR). Once 
activated by their specific ligand nuclear hormone receptors bind as monomers, 
homodimers, or heterodimers to specific sequences within the DNA known as response 
elements (Aranda and Pascual 2001).  Since the discovery of NHRs a sub-group of this 
transcription factor super family have been identified for which no ligand has been 
identified and appear to require no ligand activation.  This subgroup is termed orphan 
NHRs.   
 
1.3.2    NR4A subfamily 
A chief role ascribed to the nuclear hormone receptor NGFI-B is as a transcription factor, 
binding to DNA, and regulating gene expression.  When localized to the nucleus, NGFI-B, as 
well as Nurr1 and Nor1, can bind to the NGFI-B response elements (NBREs) as monomers or 
they can form homodimers and bind to the Nur77 response element (NuRE).  Canonically, these 
palindromic binding sequences are AAAGGTCA (NBRE) and 
TGATATTTACCTCCAAATGCCA (NuRE).  NGFI-B has also been shown to 
heterodimerize with RXR and bind to the DR5 response element (Wilson, Fahrner et al. 1991).    
Similar to other steroid hormone receptors, the NR4A family (NR4A1-3) contains 
an N-terminal transactivation domain, a zinc finger DNA-binding domain, and a C-
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controlled at the level of protein induction and posttranslational modification (Wansa, 
Harris et al. 2003; Pei, Castrillo et al. 2006).  
 
1.3.3 Regulation of NGFI-B 
1.3.3.1 Induction 
The NR4A subfamily members are considered immediate early genes (IEGs) 
because of their rapid transcription in response to diverse physiological and physical 
stimuli, including growth factors, cytokines, fatty acids, phorbol esters, neurotransmitters, 
calcium, and shear stress (Maxwell and Muscat 2006).  This ability to be rapidly induced 
in response to early changes in the cellular environment make the NR4A subfamily 
crucial in a wide variety of cellular processes.  The fact that the NR4A family members 
are considered constitutively active once present makes regulation of their induction 





Illustration 4: Regulation of the expression of NR4A family members  
NGFI-B and its close family members, Nurr1 and Nor-1, are rapidly induced by a wide 









1.3.3.2 Post-translational modifications 
Numerous studies have illustrated that the key method for regulating the ligand-less, 
orphan nuclear hormone receptors is through post-translational modifications, primarily 
phosphorylation (Wingate, Campbell et al. 2006).   These modifications affect DNA binding and 
cellular localization.  Several kinases have been shown to phosphorylate and regulate 
NGFI-B localization and function, including Akt (PkB) kinase, c-Jun N-terminal kinase 
(JNK), and ERK2 or Mitogen Activated kinase 1 (MAPK1).  In PC12 cells, an alteration 
in NGFI-B phosphorylation at Ser350 located within the “A-box” motif following 
treatment with nerve growth factor (NGF) abrogates NGFI-B DNA binding, thereby 
allowing the cells to differentiate (Katagiri, Hirata et al. 1997).  Studies also reveal 
treatment with NGF results in the phosphorylation of ser105 of NGFI-B, bolstering an 
interaction with another NHR, retinoid X receptor (RXR), and causing their export from 
the nucleus to the cytosol mediated by the nuclear export signal (NES) of NGFI-B 
(Katagiri, Takeda et al. 2000).  This NGFI-B-dependent redistribution of RXR decreases 
its ability to interact with the NHR, retinoic acid receptor (RAR), thus abrogating RXR-
RAR, retinoid-dependent transcription. These modifications differ from that witnessed 
during membrane depolarization when PC12 cells are treated with KCl, resulting in 
NGFI-B binding and transactivation of NBRE (Katagiri, Hirata et al. 1997).   Research 
also indicates that NGFI-B phosphorylation by either Akt or ERK2 in response to 
stimulation by growth factors results in the nuclear retention of NGFI-B and thus the 
promotion of proliferation and/or the prevention of cell death (Masuyama, Oishi et al. 
2001; Pekarsky, Hallas et al. 2001).   On the other hand, activation of MAP kinase 
kinase-1 (MEKK1) and JNK by various apoptotic stimuli bring about phosphorylation of 
NGFI-B resulting in its export from the nucleus and involvement in the induction of 
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apoptosis via the interaction of NGFI-B and Bcl-2 (Lin, Kolluri et al. 2004; Han, Cao et 
al. 2006). 
 
1.3.4    Physiological functions of NGFI-B 
1.3.4.1 Growth 
Although NGFI-B is induced by various growth factors, it is not clear whether 
NGFI-B is directly involved in the promotion of cell growth.  Evidence put forth by 
Kolluri et al. demonstrates NGFI-B nuclear localization and an increase NGFI-B-
dependent transactivation upon treatment with epidermal growth factor (EGF) in lung 
cancer cells (Kolluri, Bruey-Sedano et al. 2003).  Consistently, ectopic expression of 
NGFI-B promoted EGF-independent cell proliferation.  Correspondingly, studies show 
exogenous expression of NGFI-B in human umbilical vein endothelial cells (HUVEC) 
promotes vascular endothelial growth factor A (VEGF-A) – independent proliferation, 
survival, and induction of several cell cycle genes (Zeng, Westermark et al. 2006).  
Studies have also revealed treatment with VEGF not only rapidly induces NGFI-B in 
human umbilical vein endothelial cells (HUVEC), but also reduces the ser351 
phosphorylation known to reduce DNA binding and promote cytosolic translocation (Liu, 
Jia et al. 2003).  While many of the downstream targets of NGFI-B-dependent 
transcription remain unknown, it is evident in response to certain growth factor signaling, 
NGFI-B nuclear retention and transcriptional activity promotes cell growth. 
  
1.3.4.2 Cell Death 
One of the initial functions attributed to NGFI-B was the regulation of T cell receptor 
mediated apoptosis (Woronicz, Calnan et al. 1994; Cheng, Chan et al. 1997).  During the process 
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of negative selection, clonal deletions of self-reactive T cells are triggered to undergo 
programmed cell death.  While some studies have confirmed that the inhibition of NGFI-B 
prevents T cells from undergoing apoptosis and the overexpression promotes T-cell apoptosis, 
other studies have illustrated compensation for the deletion of NGFI-B by the related family 
member, Nurr1 (Winoto and Littman 2002); (Liu, Smith et al. 1994); (Lee, Wesselschmidt et al. 
1995).  The mechanism for NGFI-B’s role in T-cell receptor mediated apoptosis is attributed to 
its ability or inability to bind to DNA due to changes its phosphorylation state.  The belief that 
nuclear localized NGFI-B dictates a cell’s decision to proliferate or die was considered dogma 
until the discovery that NGFI-B could also localize to either the endoplasmic reticulum or the 
mitochondria and induce apoptosis (Rajpal, Cho et al. 2003).      Interestingly, along with p53 
and DJ-1/Park7, NGFI-B is one of only a few transcription factors established to localize 
in cytoplasmic, nuclear, and mitochondrial compartments (Hao, Giasson et al.; Springer 
and Kahle; Moll, Marchenko et al. 2006).  The mitochondrial targeting of NGFI-B in 
certain types of cancer cells appears to regulate apoptosis (Li, Kolluri et al. 2000; Lin, 
Kolluri et al. 2004)  This new localization was attributed not to the DNA binding domain of 
NGFI-B but to the ligand-binding domain despite lacking a mitochondrial localization sequence.  
The proposed method by which NGFI-B targets to the mitochondria involves interaction with the 
anti-apoptotic protein, Bcl-2.  Further investigations have offered evidence that NGFI-B’s 
interaction with Bcl-2 causes a conformational change, exposing the BH3 domain, and converting 
Bcl-2 from an anti-apoptotic protein to a pro-apoptotic protein.(Lin, Kolluri et al. 2004) (Kolluri, 




NGFI-B also accumulates in the cytosol in response to certain stimuli.  There is evidence 
translocation to the cytosol is involved in driving the cell towards differentiation as well as 
mediation of the retinoid response.(Katagiri, Takeda et al. 2000)   Several studies have 
demonstrated a unique regulation of NGFI-B in PC12 cells treated with nerve growth factor 
(NGF).   Unlike other stimuli such as the membrane depolarizing agent, KCl, and epidermal 
growth factor (EGF), as mentioned above, NGF treatment inhibits transactivation of the NGFI-B 
response elements by causing the phosphorylation of serine-350, preventing DNA binding, and 
promoting the export of NGFI-B from the nucleus (Hirata, Kiuchi et al. 1993).  Although the 
mechanism of NGFI-B regulation by NGF treatment is well described, the actual role NGFI-B 
plays in promotion of differentiation has not been well characterized.  Recent studies of 
adipogenesis in NIH-3T3 adipocytes have contradicted one another over the role of the NR4A 
family in adipocyte differentiation; however, both agree NGFI-B is transiently induced in 
response to differentiation stimuli (Au, Payne et al. 2008) (Fumoto, Yamaguchi et al. 2007). 
 
1.3.5 Disease states involving NGFI-B 
 NGFI-B is induced and activated in a wide array of tissues.  As an IEG its 
presence at the protein level is transient often lasting between 3-6 hours.  This rapid 
expression and degradation along with the tight regulation by post-translational 
modifications and cellular localization is necessary because of the constitutive activity of 
NGFI-B.  Consequently, chronic expression of NGFI-B as result of the constant presence 
of stimuli known to induce NGFI-B often contributes to certain pathologies.  For 
example, extensive investigation has revealed a role for NGFI-B in chronic inflammatory 
disorders such as rheumatoid arthritis.  NGFI-B has long been established to play a 
crucial role in the regulation of genes involved in steroidogenesis and inflammation 
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(Crawford, Sadovsky et al. 1995; Fernandez, Brunel et al. 2000; Stocco, Lau et al. 2002) 
and its cytokine-dependent induction has been exhibited in rheumatoid arthritis synovial 
tissue (Murphy, McEvoy et al. 2001).   
In the vessel wall, NGFI-B activation is associated with pathologic vascular 
remodeling associated with atherosclerotic legions in response to tumor necrosis factor- 
alpha (TNF-α), in part by inducing the plasminogen activator inhibitor-1 gene (PAI-1), 
ostensibly through an NGFI-B response element in the 5’ upstream promoter region 
(Gruber, Hufnagl et al. 2003).  NGFI-B is upregulated in macrophages stimulated by 
lipopolysaccharides (LPS), TNF-α, and phorbol 12-myristate 13-acetate and it is NGFI-B 
expressing lipid-loaded macrophages that have been discovered in atherosclerotic lesions 
(Barish, Downes et al. 2005; Pei, Castrillo et al. 2005).   
Contrary to the inflammatory disorders associated with increased or prolonged 
expression of NGFI-B, carcinogenesis is considered a pathology that could in part result 
from the loss or inhibition of NGFI-B expression.  Several cancer cell lines including 
colon, breast, prostate, and lung have demonstrated a role for NGFI-B in the induction of 
apoptosis by targeting to the mitochondria (Wu, Liu et al. 2002; Wilson, Arango et al. 
2003; Lin, Kolluri et al. 2004; Lee, Ma et al. 2005; Thompson and Winoto 2008).  This 
NGFI-B-dependent apoptotic response is attributed to its LBD which interacts with the 
anti-apoptotic protein, BcL-2 (Kolluri, Zhu et al. 2008).  The interaction between NGFI-
B and BcL-2 not only allows for mitochondrial targeting of NGFI-B despite not having a 
mitochondrial localization signal but also causes a conformational change in BcL-2, 
exposing its BH3 domain and likely preventing it from inhibiting pro-apoptotic proteins 
such as Bid and Bax (Li, Kolluri et al. 2000; Lin, Kolluri et al. 2004).  Consistently, 
abrogation of NGFI-B and Nor-1 in mice led to fatal acute myeloid leukemia (AML), 
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suggesting a role for the NR4A family as potential tumor suppressors (Mullican, Zhang et 
al. 2007).   
As a result of the pleiotropic nature of NGFI-B it is difficult to predict whether its 
prolonged presence or inhibition is going to instigate pathological signaling cascades in 
various tissues.  Further investigation is needed to understand the delicate balance 
associated with NGFI-B activity as well as better comprehension of how NGFI-B is 
regulated once present on the protein level in order to combat the diverse NGFI-B-
dependent disease states. 
 
1.4 MITOCHONDRIAL BIOENERGETICS 
1.4.1 The Mitochondria 
Often referred to as the “powerhouse” of the cell, the mitochondrion is a unique 
membrane-bound organelle found in varying numbers in most eukaryotic cells and is 
responsible for the production of chemical energy in the form of adenosine triphosphate 
(ATP).  Mitochondria are made up of specialized compartments that allow them to carry-
out its crucial function in energy production.  These sections are the intermembrane space 
and the matrix and are divided by from the cytoplasm by distinct double-phospholipid 
membranes known as the outer membrane (OM) and the inner membrane (IM).  The 
cristae are structures formed by the unique folding of the IM and a variety of membrane 
bound enzymes, including members of the electron transport chain (ETC) reside here.  
This folding increases the surface area and allows for the maximal production of ATP per 








Illustration 5: Mitochondria structural features  
Mitochondria are made up of specialized compartments that allow them to carry-out its 
crucial function in energy production.  These sections are the intermembrane space and 
the matrix and are made possible due to distinct double-phospholipid membranes known 
as the outer membrane (OM) and the inner membrane (IM).  The cristae are structures 
formed by the unique folding of the IM  







Mitochondria are believed to have originated from prokaryotic bacteria that were 
incorporated into the cell through endocytosis from which a symbiotic relationship was 
established (Sagan 1967).  The incorporation of these bacteria with respiratory abilities 
would have offered an evolutionary advantage to an organism solely producing energy 
from either glycolysis or fermentation (Bruce Alberts 2007).   Mitochondria contain their 
own DNA that is in a circular shape, similar to that found in bacteria.  This mitochondrial 
DNA (mtDNA) codes for some components of the respiratory complexes as wells as the 
ribosomes and other machinery necessary for their translation and upkeep.   
Despite the advantage mitochondria afford thanks to the massive amounts of 
chemical energy they produce, mitochondrial respiration is considered the main producer 
of ROS and therefore one of the main contributors to the ageing process and other ROS-
related disease states.  In this way, the gift of large amounts of energy production is offset 
by the introduction of ticking clock.  However, with the recent evidence that ROS are 
also crucial signaling molecules, the formation of a whole new outlook has begun 
concerning the role mitochondria play within cells.  More and more studies continue to 
uncover new regulatory roles for the mitochondria and further investigation may uncover 
an exciting link between several cellular signal transduction pathways and the products 
produced by the mitochondria. 
 
1.4.2 The Electron Transport Chain (ETC) 
The ETC consists of a series of electron donors and acceptors within the 
mitochondria of eukaryotic cells.  Products generated by the Krebs cycle within the 
mitochondrial matrix, NADH and succinate FADH2, donate electrons to NADH 
coenzyme Q reductase (Complex I) and succinate dehydrogenase (Complex II), 
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respectively.  These electrons continue to be passed along the ETC from donor to a more 
electronegative acceptor until they are delivered to the most electronegative acceptor, 
oxygen thereby reducing oxygen to water.  Once electrons have been delivered to 
Complex I and II, these complexes each donates its electrons to coenzyme Q.  Coenzyme 
Q passes electrons to the cytochrome bc1 complex (Complex III) which then donates 
electrons to cytochrome c.  Electrons are finally passed from cytochrome c to cytochrome 
c oxidase (Complex IV), which reduces molecular oxygen to water.   
This flux of electrons through the chain generates energy and causes 
conformational changes allowing for proton pumping (four from Complexes I and IV and 
six from Complex III) from the matrix to the intermembrane space.  This creates an 
electrochemical proton gradient known as the mitochondrial membrane potential (MMP).  
The matrix, containing fewer protons than the intermembrane space, is more electro-
negative therefore given the opportunity protons will naturally want to flow back into it.  
The lipid bi-layer making up the intermembrane maintains this membrane potential 
leaving only the F1/F0 ATPase synthase as a means for protons to flow back through to 




Illustration 6: The mitochondrial electron transport chain 
The ETC consists of a series of electron donors and acceptors within the mitochondria. 
Products generated by the Krebs cycle within the mitochondrial matrix, NADH and 
FADH2, donate electrons to NADH coenzyme Q reductase (Complex I) and succinate 
dehydrogenase (Complex II), respectively.  These electrons continue to be passed along 
the ETC from donor to a more electronegative acceptor until they are delivered to the 
most electronegative acceptor, oxygen thereby reducing oxygen to water. This flux of 
electrons through the chain generates energy and causes conformational changes allowing 
for proton pumping from the matrix to the intermembrane space creating an 
electrochemical proton gradient.  This electrochemical gradient provides the driving force 
for the production of ATP from ADP by the F1/F0 ATPase synthase. 
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1.4.2 The Mitochondrial Membrane Potential (MMP) 
The mitochondrial membrane potential is the voltage difference between the 
mitochondrial intermembrane space and the matrix.  Nobel Laureate, Peter Mitchell 
discovered the mitochondrial membrane potential is the driving force for the generation 
of energy in the form of ATP (Mitchell 1966; Mitchell 1979).  NADH and FADH2 are 
capable of donating their electrons to Complex I or Complex II, respectively.  This 
reaction is coupled to the pumping of protons from the matrix to the intermembrane 
space.  The accumulation of protons in the intermembrane space gives it a positive charge 
compared to the matrix creating an electrochemical gradient that drives protons through 
the ATPase thereby generating ATP (Mitchell 1979).  So in order for the mitochondria to 
produce ATP efficiently and the cell to remain viable it is important to maintain this 
membrane potential. 
1.4.2.1 Regulators of MMP 
As other roles of the mitochondria within the cell have been discovered the 
mitochondria membrane potential has become an important indicator of mitochondrial 
functions such as apoptosis and ROS production.  Still, controversy exists regarding the 
different mechanisms by which the MMP is regulated.  One theory involves the 
mitochondrial permeability transition pore (MPTP).  The voltage-dependent anion 
channels (VDAC), adenine nucleotide translocase (ANT), and cyclophillin d combine to 
form what is commonly referred to as the MPTP (Halestrap, McStay et al. 2002).  The 
pore exists in three main positions.  The MPTP can be found in a closed position, 
characterized by an intact MMP and functioning oxidative phosphorylation.  Partial 
opening of the MPTP or “low conductance” allows for the influx of ions 300 Daltons or 
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less and the reversible loss of the MMP.  “High conductance” or full opening of the 
MPTP is associated with an irreversible loss of MMP.  Complete opening of the MPTP 
leads to an increase in mitochondrial permeability to solutes less than 1.5 kDa (Ichas and 
Mazat 1998; Gottlieb 2001; Ly, Grubb et al. 2003).  Studies have shown that alterations 
in either cytoplasmic or mitochondrial calcium concentrations can trigger the pore to 
open and cause temporary loss of membrane potential (Gunter, Buntinas et al. 2000).  
Research also suggests that the regulation of MPTP opening is crucial to protecting tissue 
from the excessive oxidative stress that is associated with ischemia-reperfusion injury 
(Saotome, Katoh et al. 2009).   
Others suggest the opening of the MPTP allows for the release of apoptotic 
factors, including cytochrome c, apoptosis inducing factor (AIF), and Smac/Diablo, from 
the mitochondria (Smaili, Hsu et al. 2000).  Disagreement exists concerning the 
mechanism by which the MPTP regulates apoptosis.  It is believed by some that opening 
of the MPTP results in the influx of ions such as potassium, magnesium, and calcium, as 
well as water (Bernardi, Vassanelli et al. 1992).  This causes the mitochondria to swell 
and the outer mitochondrial membrane to burst (Crompton 1999).  Studies using the 
cyclophilin d inhibitor cyclosporin A (CspA) appears to block apoptosis in some cell 
lines, lending strength to this particular theory (Petronilli, Cola et al. 1993).  However, 
other research has shown circumstances in which the MPTP remained closed and the 
MPP intact despite cytochrome c release and caspase activation (Bossy-Wetzel, 
Newmeyer et al. 1998).  Controversy still surrounds the exact role the MPTP has in 
mitochondrial function.  A variety of theories exist concerning the involvement of the 
MPTP in regulating cellular calcium, the release of apoptotic factors, as well as the 
regulation of mitochondrial ROS production.  Evidence suggests that it is likely involved 
in all of these processes, therefore to further understand these possibilities more research 
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is needed to define the mechanism by which the MPTP opens and closes and its 
regulation by specific factors. 
Uncoupling proteins (UCPs) are intermembrane proteins located within the 
mitochondrial inner membrane also known to lower MMP.  The involvement of the first 
uncoupling protein, aptly named UCP1, in cold-induced thermogenesis in mammalian 
brown adipose tissue has been well established (Girardier and Schneider-Picard 1983; 
Cannon and Nedergaard 2004).  Research has demonstrated that upon activation UCP1, 
and its close homologues UCP2 and 3, leak protons from the intermembrane space back 
into the mitochondrial matrix (Mills, Banks et al. 2003; Esteves and Brand 2005).  This 
UCP-dependent proton conductance uncouples electron transport from the oxidative 
phosphorylation of ADP to ATP releasing the energy lost as heat resulting in an increase 
in oxygen consumption and the decrease of the MMP (for a comprehensive review see 
(Garlid, Jaburek et al. 2001; Brand and Esteves 2005; Krauss, Zhang et al. 2005).  The 
lowered MMP, allows electrons to flux more efficiently through the ETC, thereby 
preventing the slippage of electrons at Complex I and III decreasing the generation of 
superoxide (Brand, Affourtit et al. 2004; Brand, Buckingham et al. 2004).  The ability of 
the mitochondria to regulate how much ROS is produced suggests that the mitochondria 
could be actively involved in cellular redox-signaling, and  that the MMP could be used 
as an indicator of this involvement. 
Loss of MMP has also been associated with the intrinsic apoptotic pathway.  Pro-
apoptotic members of the Bcl-2 family including Bid, Bak, and Bax are thought to allow 
for Bax homo-oligomerization which creates pores within the outer membrane (Silke and 
Vaux 1998; Korsmeyer, Wei et al. 2000; Yin 2000).  This allows for the release of pro-
apoptotic proteins from the mitochondria, such as cytochrome c, and leads to the 
activation of caspase-9 and the formation of a multimeric apoptosome complex (Zou, Li 
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et al. 1999).  Eventually, caspase-3 is cleaved resulting in the further propagation of cell 
death (Zou, Li et al. 1999; Acehan, Jiang et al. 2002).  These pores not only allow 
mitochondrial proteins to enter the cytosol, but also allow the release of protons into the 
cytosol, triggering a loss of membrane potential.  However, as a result of the rapid nature 
of programmed cell death it is unclear whether regulation of membrane potential is 
necessary for programmed cell death or merely an artifact.  Studies have also indicated 
that upon activation, caspases enter the mitochondria and cleave the p75 subunit of 
respiratory Complex I rendering it inactive (Ricci, Munoz-Pinedo et al. 2004).  This 
results in a reduction in protons being pumped into the intermembrane space thus 
lowering the MMP by an entirely different mechanism. 
 
1.5 SIGNIFICANCE OF STUDYING THE REDOX REGULATION OF NGFI-B 
As reviewed by Maxwell et. al., (Nuclear Receptor Signaling, 2005), NGFI-B 
responds to diverse stimuli that are also associated with increased production of cellular 
ROS, including prostaglandins, phorbol esters, fatty acids, cell stress, mechanical 
agitation, mitogenic growth factors, and inflammatory cytokines.  Though its physiologic 
functions are far from fully established, NGFI-B is involved in dopaminergic neuronal 
development, steroidogenesis, T-cell selection (apoptosis), and adipose development.  
Arguably, the most important disease association for NGFI-B is atherosclerosis, which is 
strongly linked to oxidative stress and vascular remodeling involving circulating 
macrophages, and vessel wall endothelial and smooth muscle cells (Zafari, Ushio-Fukai 
et al. 1998).  In the vessel wall, NGFI-B activation is associated with pathologic vascular 
remodeling in response to tumor necrosis factor-1 alpha (TNF-α).  This NGFI-B 
activation results in the downstream induction of the plasminogen activator inhibitor-1 
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(PAI-1) gene, ostensibly through an NGFI-B response element in the 5’ upstream 
promoter region (Gruber, Hufnagl et al. 2003).  Similarly, TNF-α is well known to 
increase endothelial ROS production; and increased vascular oxidative stress and PAI-1 
levels each is associated with vascular disease risk (Li and Fukagawa).  NGFI-B 
induction occurs in response to smooth muscle cell proliferative stimuli as well as low 
concentrations of exogenous hydrogen peroxide.  Thus, reductive inhibition of NGFI-B 
in the vasculature may comprise a new therapeutic avenue for the prevention of 
neointimal formation, and plaque development during atherogenesis. 
It is also well established that oxidative stress and dependence on both mitogenic 
and anti-apoptotic ROS signaling in cancer cells represent specific vulnerabilities that can 
be selectively targeted.  This new form of chemotherapy, termed redox chemotherapy, 
utilizes direct- or indirect-acting redox modulators as adjuncts to other chemotherapeutic 
drugs in order to better target and treat certain types of cancer (for a comprehensive 
review (Wondrak 2009).  In a wide variety of cancer cells lines the translocation of 
NGFI-B to the mitochondria in response to apoptotic stimuli has been observed (Li, 
Kolluri et al. 2000; Wu, Liu et al. 2002; Lin, Kolluri et al. 2004; Lee, Cobb et al. 2007; 
Thompson and Winoto 2008).  This new localization was not dependent on its DNA 
binding domain, but rather to the ligand-binding domain despite lacking a mitochondrial 
localization sequence.  NGFI-B induction occurs after treatment with the tumor promoter 
and ROS generator, TPA and studies in cardiomyocytes have revealed mitochondrial 
localization by NGFI-B under oxidative stress (Cheng, Volkers et al.).  These findings 
along with the discovery that gene knockouts of NGFI-B and Nor-1 lead to acute myeloid 
leukemia in mice (Mullican, Zhang et al. 2007) suggest further understanding of the 
redox regulation of NGFI-B is necessary and could lead to the development of potential 
therapeutic strategies in the treatment of cancer. 
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Long term exposure of dopaminergic neurons to pro-oxidant conditions increases 
their susceptibility to apoptosis and this exposure is suspected to be associated with the 
neurological diseases such as Parkinson’s disease (No, Bang et al.; Kulich and Chu 
2003).  Whether oxidants are a cause or the consequence of neuropathologies, such as 
Parkinson’s, remains unclear.  However, the association of increased oxidant production 
with dopamine metabolism suggests their role is worth further investigation.  
Interestingly, the close family member of NGFI-B, Nurr1, is not only shown to be 
expressed in the central nervous system, including the substantia nigra, but knock down 
of Nurr1 results in increased apoptosis in the midbrain dopaminergic neurons known to 
deteriorate in Parkinson’s disease  (Rhee, Chang et al. 2003; Jankovic, Chen et al. 2005).  
Enhanced comprehension of how NGFI-B and the other NR4A family members respond 
to ROS signaling will possibly lead to better treatments for and understanding of 
neuropathologies such as Parkinson’s and Alzheimer’s disease. The results put forth in 
this body of work provide a new biochemical framework to begin to address potential 
mechanisms linking NGFI-B and cellular redox changes to similarly pleiotropic 
physiological and pathological processes. 
 
1.6 SIGNIFICANCE OF NGFI-B REGULATED MMP LOSS IN SKELETAL MUSCLE CELLS 
NGFI-B was characterized initially for its involvement in T-cell selection through 
apoptosis.  The role of NGFI-B in the apoptotic process was originally believed to 
involve nuclear localization NGFI-B-dependent transcription. Consistent with this idea, 
overexpression of a dominant-negative NGFI-B protein that inhibited the activity of all 
three NR4A family members prevented T-cell negative selection (apoptosis) (Calnan, 
Szychowski et al. 1995; Zhou, Cheng et al. 1996).  Additionally, several downstream 
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targets of NGFI-B-dependent transcription such as TRAIL, Fas ligand, and NDG1 are 
associated with the activation of apoptosis through caspase-8 and the death receptor 
pathway (Rajpal, Cho et al. 2003). This evidence along with experiments showing that 
both constitutive expression of NGFI-B as well as transient expression of a mutant form 
of NGFI-B with higher transcriptional activity lead to massive apoptosis in thymocytes 
highly suggests that NGFI-B-dependent transcription is likely at the root of its apoptotic 
function (Cheng, Chan et al. 1997; Kuang, Cado et al. 1999).  However, studies using a 
dominant negative form of the protein FADD that blocks death receptor signaling 
revealed thymocytes still underwent negative selection implying other apoptotic 
mechanisms may be at play, including the translocation of NGFI-B to the mitochondria 
(Newton, Harris et al. 1998).  
More recently, evidence in not only thymocytes, but a variety of cancer cell lines 
has indicated a mitochondrial localization of NGFI-B in response to a variety of apoptotic 
stimuli that appears to promote cell death (Li, Kolluri et al. 2000; Wu, Liu et al. 2002; 
Wilson, Arango et al. 2003; Lin, Kolluri et al. 2004; Lee, Ma et al. 2005; Thompson and 
Winoto 2008).  Zhang et al. have shown that NGFI-B requires an interaction with Bcl-2 
in order to induce apoptosis in prostate cancer cells (Li, Kolluri et al. 2000; Lin, Kolluri 
et al. 2004).  In their reports, the ligand-binding domain of NGFI-B causes a 
conformational change in Bcl-2 that converts it to a pro-apoptotic protein by exposing its 
BH3 domain (Lin, Kolluri et al. 2004).  Numerous other publications corroborate NGFI-
B mitochondrial localization and the regulation of the BH3-exposed Bcl-2 in apoptosis in 
a variety of cells lines.  However, the physiological relevance and overall mechanism by 
which NGFI-B activates programmed cell death remains largely unknown. 
The discovery that both transient and stable expression of NGFI-B in L6 skeletal 
muscle cells resulted in the loss of MMP in the absence of any apoptotic stimuli led us to 
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hypothesize that this could possibly be an early event in NGFI-B-dependent cell death 
induction.  Muscle cells, like neuronal cells, are resistant to cell death compared to other 
cell types, especially once they have differentiated (Wang and Walsh 1996; Kamradt, 
Chen et al. 2002).  This resistance to cell death is crucial because skeletal muscle is a 
primary site of fatty acid oxidation and glucose disposal and largely involved in insulin 
sensitivity and obesity (Maxwell, Cleasby et al. 2005; Chao, Zhang et al. 2007). Muscle 
fibers being post-mitotic ensure that once lost they can never be regained therefore 
resulting in the total loss of their functional outputs. NGFI-B has been previously 
described by George Muscat’s lab to be upregulated in C2C12 muscle cells by the β-
adrenergic receptor (β-AR) agonist isoprenaline.  Using siRNA mediated knockdown of  
NGFI-B, several genes involved in energy expenditure and lipolysis were downregulated, 
including the uncoupling proteins UCP2 and UCP3 (Maxwell, M 2005 JBC). Likewise, 
NGFI-B induction by β-AR stimulation was demonstrated and linked to the induction of 
the uncoupling protein, UCP1, in brown adipocytes of cold-induced mice (Kanzleiter, 
Schneider et al. 2005).  This evidence not only suggests cross-talk between the β-AR and 
nuclear hormone receptor signaling but also provides a possible mechanism by which 
NGFI-B indirectly lowers MMP through the upregulation of uncoupling proteins.  
However, oxygen consumption experiments using stable L6 muscle cells, expressing 
either empty vector or NGFI-B, revealed a significant difference in State 3 respiration but 
no differences in State 4 respiration. This suggests that the NGFI-B-dependent alteration 
of MMP is not caused by proton leak.  Further, systematic, exploration into how NGFI-B 
is regulating the MMP will lead to a better understanding of how mitochondria regulate 
signal transduction pathways and may reveal a mechanism for NGFI-B-dependent cell 
death induction. 
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1.7 DISSERTATION OBJECTIVES 
The primary focus of my work was to characterize a unique redox signaling 
pathway involving the orphan nuclear hormone receptor NGFI-B.  I initially approached 
this objective by demonstrating that NGFI-B-mediated transcription plays a novel role as 
a sensor coordinating cellular redox status and the regulation of gene expression.   
Notably, both exogenous oxidants and physiologically-relevant NGFI-B-inducing stimuli 
can stimulate NGFI-B induction and activity in multiple cell types.  Correspondingly, 
experiments also demonstrate that NGFI-B-dependent transcription is potently inhibited 
by thiol-reducing agents through a novel interaction between NGFI-B and the cellular 
thiol reducing enzyme thioredoxin 1 (Trx1).  Together, these studies reveal a hitherto 
unappreciated role for NGFI-B as a mediator of a redox-sensitive pathway of gene 
regulation.  Moreover, the studies add NGFI-B to an expanding portfolio of potential 
substrates for Trx1, and shed light on a novel, inhibitory function of Trx1 in the 
regulation of gene expression.  This work lays the foundation for future work aimed at 
understanding in more detail the direct and/or indirect biochemical mechanisms 
underlying the redox regulation of NGFI-B in more detail. 
The second part of my work stemmed from a unique discovery that stable 
expression of NGFI-B in L6 skeletal myoblasts resulted in the loss of MMP.  Further 
characterization of this finding indicated that while these cells basally expressed full-
length NGFI-B they did not appear to undergo apoptosis.  The loss of MMP often 
preceeds apoptosis and signifies damage to or disruption of the outer mitochondrial 
membrane.  It is unclear, however, if the loss of MMP is a necessary step in the apoptotic 
process or simply a consequence of the intrinsic apoptosis pathway.  On one hand, it 
makes sense that the MMP would be lost upon outer membrane disruption.  However, 
very little is still know regarding the maintenance of the MMP, and a variety of other 
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factors, including the MPTP and uncoupling proteins, have been shown to temporarily 
abrogate the MMP for reasons other than cell death induction.  Further investigation into 
the mechanism by which NGFI-B regulates the MMP in L6 muscle cells could advance 















Chapter 2: Methods and materials 
 
2.1 METHODS AND MATERIALS FOR CHAPTER 3 
2.1.1 Plasmid DNA constructs 
The full-length coding sequence of mouse NGFI-B was sub-cloned into the 
pcDNA6/myc-His vector (Invitrogen) in using EcoRI and XhoI.  Full-length human 
thioredoxin1 was sub-cloned using BamHI and XbaI into pcDNA3.1/V5-His 
(Invitrogen).  The NBRE luciferase reporter construct (JA982) containing three 
consecutive NBRE sequences upstream of the luciferase gene was a gift from Jacques 
Drouin, University of Montreal, Montreal, Canada.  The ΔAF-1-NGFI-B-myc construct 
was generously provided by Justin Rochford, University of Cambridge, United Kingdom. 
 
2.1.2 Cell Culture and Transfection Assays 
PC12 rat pheochromocytoma cells grown on collagen type IV coated plates/flasks 
in DMEM (Mediatech) growth medium containing 10% fetalplex serum (Gemini) and 
1% penicillin/streptomycin (Gibco).  PC12 cells were grown in collagen coated flasks to 
improve their adherence.   The culture medium was changed every 2 days.  Rat vascular 
smooth muscle cells (VSMC) and Hek293T cells were cultured in DMEM growth 
medium containing 10% fetal bovine serum and 1% penicillin/streptomycin.   
 
2.1.3 Immunoblotting 
Lysates were prepared in RIPA buffer (50mM Tris-HCl, 1% NP40, 0.5% sodium 
deoxycholate, 0.1% sodium dodecyl sulfate (SDS), 150mM sodium chloride (NaCl), 
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2mM EDTA, pH 8.0).  A bicinchoninic assay (Pierce Biotechnology) was used to 
quantify total protein concentrations.  Samples were prepared with 4X sample buffer 
(250mM Tris-HCl, 8% SDS, 40% glycerol, 8% betamercaptoethanol, 0.02% 
bromophenol blue) and separated by electrophoresis on 12.5% polyacrylamide gels.  
Proteins were transferred to a nitrocellulose membrane and probed with primary antibody 
according to the manufacturer’s instructions.  Antibodies used were mouse monoclonal 
2E1 antibody specific for Nur77 (a gift from Jeffery Milbrandt, Washington University, 
St. Louis, MO), rabbit polyclonal anti-V5 (Abcam), mouse monoclonal anti-myc (Cell 
Signaling), rabbit polyclonal anti-Nur77 M-210 (Santa Cruz Biotechnology), or rabbit 
polyclonal anti-Trx1 (Cell Signaling, Danvers, MA) .  Secondary antibodies included 
donkey anti-rabbit 1:3000 and sheep anti-mouse 1:3000 (Amersham Biosciences).  
Membranes were processed using Pierce Super Signal West Pico chemiluminescent 
solution (Pierce). 
 
2.1.4 Dual-Luciferase Assay 
500,000 PC12 cells/well were seeded onto collagen-coated 6 well plates.  Cells 
were transfected the following day with 1ug/well of the NBRE luciferase reporter and 
0.1ug/well of the pRL-TK renilla construct using Lipofectamine according to 
manufacturer instructions (Invitrogen).  2 days after transfection, cells were treated with 
50mM potassium chloride (KCl), 20mM caffeine, 100 µM/200 µM hydrogen peroxide 
(H2O2), 10 µM antimycin A, 2.5 mM pyruvate/2.5 mM malate (P/M), 5 mM succinate 
and/or 2 mM dithiothreitol (DTT) for 8 hours and luciferase activity was assessed using 
the dual-luciferase kit (Promega). 
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2.1.5 Redox Western Blotting for Trx1 and ΔAF-1-NGFIB-myc 
The redox state of Trx1 and ΔAF-1-NGFIB-myc was determined by analysis of 
cell extracts pre-incubated with AMS (4-acetamido-4′-maleimidylstilbene-2,2′-disulfonic 
acid) as previously described (Hirasaka, Lago et al.). Briefly, cells were either untreated 
or treated with 5mM DTT or 500 µM-5mM hydrogen peroxide and precipitated with 
10% ice-cold trichloroacetic acid for 30 min at 4°C. Samples were centrifuged at 12,000g 
for 30 min, resuspended in 100% acetone and incubated at 4°C for 30 min. Following 
centrifugation at 12,000g for 10 min, the acetone was removed and protein pellets were 
dissolved in 20mM Tris/HCl, pH 8.0, containing 15 mM AMS and incubated at room 
temperature (25°C) for 3 hours.  Trx1 and ΔAF-1-NGFIB-myc redox forms were 
separated by SDS-PAGE using a non-reducing loading buffer (300mM Tris-HCl, pH 6.8, 
50% glycerol, 10% SDS, 0.05% bromophenol blue). 
 
2.1.6 Site-Directed Mutagenesis 
An active site double cysteine to serine mutant thioredoxin1 (C32S, C35S) was 
generated using the QuickChange Site Directed Mutagenesis kit (Stratagene) using the 




Co-immunoprecipitation (IP) experiments were performed in Hek293T cells 
transfected with combinations of NGFI-B-myc, Trx1-V5, or the active site mutant Trx1-
V5 using calcium phosphate.  Cells were lysed with RIPA buffer containing protease and 
phosphatase inhibitors (Roche).  Lysates using 1-2mg of protein/sample were adjusted to 
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500ul with lysis buffer and incubated with 2ug anti-V5 antibody (Abcam) or rabbit IgG 
(for controls) overnight at 4°C.  Thirty microliters of protein G sepharose beads 
(Amersham Biosciences) were added to each lysate and incubated at 4°C for an 
additional 16 hours.  Samples were washed six times in lysis buffer after which samples 
were prepared for SDS-PAGE as described above. 
 
2.1.8 Endogenous Co-Immunoprecipitation 
PC12 cells were seeded at 5 x 10^6 cells/plate and were either left untreated or 
treated with 20mM caffeine for 3 hours to induce endogenous NGFI-B.  IP samples were 
then processed using a lysis buffer containing 50mM Tris-HCl, 150mM NaCl, 5mM 
EDTA, 1% Triton-X, and protease inhibitors.  IP samples (500ug protein/sample) were 
then incubated with 2ug of anti-Nur77 m-210 antibody (Santa Cruz Biotechnology) or 
IgG (for controls) at 4°C for 4 hours with rotation.  IP sampled were then processed as 




Statistical evaluation of the data was performed using ANOVA followed by a 
Dunnett’s post hoc test with a significance set a priori as p<0.05.  Data represent 
averages +/- standard error of the mean (SEM) from at least 3 independent experiments. 
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2.2 METHODS AND MATERIALS FOR CHAPTER 4 
2.2.1 Plasmid construction 
The full-length coding sequence of mouse NGFI-B was sub-cloned into the 
pcDNA6/myc-His vector (Invitrogen) in using EcoRI and XhoI.  Full-length mouse 
NGFI-B was also cloned into the FG9 lentiviral vector (kindly provided by Dr. Casey W. 
Wright, UT-Austin, TX, USA).  The myc-tagged Bax vector was provided by Dr. Shawn 
Bratton, UT-Austin, TX, USA). 
 
2.2.2 Cell Culture and Transfection assays 
Rat L6 skeletal muscle cells and HeLa cells were cultured in DMEM growth 
medium containing 10% fetal bovine serum (Gemini) and 1% penicillin/streptomycin 
(Gibco).  All transient transfection assays were carried out according to manufacturer 
instructions using TransIT®-LT1 transfection reagent (Mirius). 
 
2.2.3 Lenti-viral Infection 
Hek293T cells were seeded in at approximately 5 million cells per dish and 
allowed to adhere overnight in DMEM + 10% FBS.  The next morning, cells were 
transfected (via calcium chloride transfection) with 5µg each of the viral packaging 
constructs FG9-CMV, FG9-RRE, FG9-REV, and 5µg of either FG9-empty vector (FG9-
EV) or FG9-NGFI-B per plate of HEK cells.  Briefly, all four constructs for each 
transfection were diluted in 1.5 mL sterile, DEPC treated ddH2O with 250mM CaCl2 
(final concentration).  DNA/CaCl2 mixture was added to an equal volume of 2x HBS 
while mixing vigorously and then allowed to incubate at room temperature for 15 
minutes.  Old media on the Hek293T plates was replaced with 9mL of DMEM + 10% 
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FBS + 25µM chloroquinone.  1 mL of transfection mixture was added drop-wise to each 
plate and swirled to mix.  Plates were incubated at 37°C for 7 hours, then checked for 
precipitate formation to confirm successful transfection, and media was changed to 7mL 
of DMEM +10% FBS. Cells were then cultured in media supplemented with hygromycin for 1 
week, then harvested via trypsinization and transferred to 10cm dishes.  Cells were allowed to 
grow for an additional 2.5 weeks, until single colonies could be selected and screened. 
 
2.2.4 Assessment of MMP by fluorescent microscopy 
L6 skeletal muscle cells, 50,000 cells/glass chamber well, were transfected with 
either pEGFP or GFP-NGFI-B using TransIT®-LT1 transfection reagent (Mirius).  After 
24, 48, and 72 hours cells were stained with 25 nM tetramethylrhodamine, methyl ester, 
perchlorate  (TMRM; Molecular Probes) for 10 min in the dark at 37°C, washed three 
times with Hanks balanced salts solution (HBSS, Sigma) and imaged using fluorescent 
microscopy (Nikon Eclipse TI-S). 
 
2.2.5 Assessment of MMP by flow cytometry 
L6 muscle cell lines (1x106) stably expressing either empty FG9 vector or FG9-
NGFI-B were incubated with tetramethylrhodamine, methyl ester, perchlorate (25 nM 
TMRM; Molecular Probes) for 10 min in the dark at 25°C. Cells exhibiting red (λex/λem= 
488/ 620 nm) were assayed by flow cytometry (Beckman-Coulter FC500). 
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2.2.8 Mitochondrial cytochrome C release 
L6 myoblasts (2 x 106) were transfected with empty pcDNA6/myc-His vector 
(Invitrogen), myc-tagged NGFI-B, myc-tagged Bax or exposed to UVB irradiation (5 
min on a UV illuminator), washed with PBS, and resuspended in 100 μL of digitonin 
lysis buffer (75 mM KCl, 1 mM NaH2PO4, 8 mM Na2HPO4, 250 mM sucrose, 60 μg/mL 
of digitonin) for 10 min on ice. Cytosolic fractions were then collected by centrifugation 
(15,000 x g; 10 min) and immunoblotted with a mouse anti-cytochrome c antibody (clone 
6H2.B4, BD Pharmingen). 
 
2.2.9 Whole cell oxygen consumption  
Oxygen consumption analyses were performed (N>3 times in triplicate) using a 
Clark-type electrode as described previously (Brand et al., 2005; Hoppel et al., 1979) 
with minor modification. Briefly, respiration of 4 x 10^6 L6 muscle cells stably 
expressing either empty FG9 or FG9-NGFI-B were assayed in 1 mL Hanks balanced salts 
solution (HBSS, Sigma)  by the sequential addition of oligomycin (1μg/ml) and 
dinitrophenol (DNP, 250μM).  Slopes were recorded and statistical analysis using a 






Chapter 3: Redox regulation of the transcription factor NGFI-B 
3.1 INTRODUCTION 
ROS generated at supraphysiologic levels can indiscriminately oxidize and 
damage lipids, DNA, and proteins.  Alternatively, the ability of the cell to control redox 
homeostasis has supported the hypothesis that ROS are discretely controlled and 
therefore serve as second messengers.  This balance allows the cell to respond to slight 
changes in the redox state for the purpose of altering gene expression and modifying 
signaling pathways, thereby navigating the cell’s fate (Allen and Tresini 2000; Balaban, 
Nemoto et al. 2005; D'Autreaux and Toledano 2007; Genestra 2007). Oxidants are 
capable of directly and indirectly altering cell function, whether it be the oxidant burst in 
response to growth factors that deactivate phosphatases and allow for the propagation of 
kinase signaling (Lee, Kwon et al. 1998; Rhee, Bae et al. 2000; Kwon, Lee et al. 2004) or 
by directly altering transcription factors in response to oxidative stress to translocate into 
the nucleus and transcribe antioxidant genes (Allen and Tresini 2000).   While a wide 
array of pathways have been well characterized within the cell further understanding of 
how these pathways are coordinated to one another and to the cells needs remains 
unclear. 
 Our research reveals one potential redox target is the transcription factor NR4A1 
also known as NGFI-B, Nur77, and TR3.  The NR4A family, like other steroid receptors 
contains an N-terminal transactivation domain, a zinc finger DNA-binding domain, and a 
C-terminal ligand-binding domain (Hsu, Zhou et al. 2004).  However, three-dimensional 
studies of the structure of NGFI-B and its closest relatives, Nor1 and Nurr1, have 
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revealed the NR4A family contains an atypical ligand-binding domain rendering it unable 
to bind stereotypical ligands such as steroids, fatty acids, retinoic acids, as well as other 
lipophillic molecules (Maxwell and Muscat 2006) (Wang, Benoit et al. 2003).  Hence, the 
NR4A family members have been considered orphan nuclear hormone receptors because 
no physiological ligand has been identified that regulates their functions.  The majority of 
research suggests the activity of the NR4A family members is mainly controlled by the 
level of protein induction and posttranslational modifications (Wansa, Harris et al. 2003) 
(Pei, Castrillo et al. 2006).  NGFI-B also belongs to a small group of transcription factors 
capable of translocating to both the nucleus where it regulates gene expression and to the 
mitochondria where it is involved in the induction of apoptosis (Li, Kolluri et al. 2000; 
Lin, Kolluri et al. 2004).  Even more interesting is the fact several of the stimuli involved 
in NGFI-B induction and activation are also associated with increased levels of 
intracellular ROS (Sundaresan, Yu et al. 1995; Bae, Kang et al. 1997; Colavitti, Pani et 
al. 2002) (Slater, Nobel et al. 1995).  A variety of disease states for which NGFI-B is 
heavily involved in also reveal an integral role for redox disruption, including cardiac 
ischemia, atherosclerosis, and carcinogenesis (Cheng, Volkers et al.; Zhao, Howatt et al.; 
Wu, Liu et al. 2002; Pei, Castrillo et al. 2005; Mullican, Zhang et al. 2007). 
Here, we demonstrate that the NGFI-B-mediated transcriptional regulatory 
pathway plays a novel role as a signal transduction relay between cellular redox status 
and the regulation of gene expression.   Notably, both exogenous oxidants and 
physiologically-relevant NGF-B-inducing stimuli could stimulate NGFI-B induction and 
activity in multiple cell types.  Correspondingly, experiments also demonstrate NGFI-B-
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dependent transcription is potently inhibited by thiol-reducing stimuli through a novel 
identified interaction between NGFI-B and the cellular thiol reducing enzyme thioredoxin 
1 (Trx1). 
3.2 RESULTS 
3.2.1 Redox regulation of NGFI-B induction 
NGFI-B is encoded by an immediate early gene (NR4A1) that is rapidly induced 
by a variety of physiologic and pharmacologic stimuli, including potassium chloride 
(KCl), platelet derived growth factor (PDGF), epidermal growth factor (EGF), nerve 
growth factor (NGF), and caffeine (Milbrandt 1988; Katagiri, Hirata et al. 1997; Lammi 
and Aarnisalo 2008; Martin, Boucher et al. 2009).  To test the hypothesis that NGFI-B 
expression is redox-sensitive, we treated both rat pheochromocytoma (PC12) and 
vascular smooth muscle (VSMC) cells with a range of doses of hydrogen peroxide and 
quantified NGFI-B protein levels using immunoblotting.  Low micromolar concentrations 
of exogenous hydrogen peroxide (100 µM and 200 µM H2O2) significantly induced 
NGFI-B in a dose and time-dependent manner in both PC12 and VSMC cultures (Figure 
3.1A,B, and 3.2B). To define the physiological relevancy of oxidant-induced NGFI-B 
induction, cells were pretreated with the thiol reducing agent DTT and subsequently 
treated with the NGFI-B-inducing stimuli caffeine, KCl, EGF, or NGF.  As shown in Fig. 
3.2 A and B, DTT pre-treatment significantly attenuated the induction of NGFI-B in both 
PC12 cells and VSMC cells by EGF, NGF, and caffeine, but not by KCl (Figure 3.2A,B). 
Thus, the physiological induction of the NR4A1 immediate early gene exhibits complex 
regulation by both redox-sensitive and redox-independent mechanisms. 
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 Figure 3.1 Regulation of NGFI-B induction 
(A)  Western blot of NGFI-B protein levels in rat pheochromocytoma (PC12) 
cells in response to no treatment (NT) or treatment of cells with the 
positive control KCl (50 mM), or a range of doses of hydrogen peroxide 
for 180 min.   
(B) Time-course of NGFI-B protein induction in PC12 cells in response to 200 
µM hydrogen peroxide.  (A-B) For both western blots glyceraldehyde 3-
phosphate dehydrogenase (GAPDH, bottom) protein levels were used to 
control for total protein on the membrane 
 63
 
 Figure 3.2 DTT inhibits NGFI-B induction by physiological inducers 
(A)  Effects of the thiol reducing agent, DTT (2 mM, 30 min.) on NGFI-B by 
induction in PC12 cells in response to caffeine, KCl, or NGF. 
(B) Effects of DTT pretreatment (2 mM, 30 min.) on NGFI-B induction in 
response to hydrogen peroxide (200 µM, 90, 180 min.), caffeine (20 mM, 
180 min) and EGF (100 ng/uL, 90 min) in VSMC cells.  (A-B) For both 
western blots glyceraldehyde 3-phosphate dehydrogenase (GAPDH, 
bottom) protein levels were used to control for total protein on the 
membrane. 
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3.2.2 Redox regulation of NGFI-B-driven gene expression 
Having established that NGFI-B expression is redox-sensitive, we next tested 
whether the transcriptional regulatory function of NGFI-B was also redox-controlled.  
NGFI-B binds to DNA as a monomer at the NGFI-B response element (NBRE) and as a 
homodimer or heterodimer with the other NR4A family members (Nurr1 and Nor1) to 
the Nur77 response element (NuRE).  Canonically, these palindromic binding sequences 
consist of the octanucleotide AAAGGTCA motif for the NBRE, and the everted repeat 
AAAT(G/A)(C/T)CA motif for the NuRE.  NGFI-B can also heterodimerize with the 
steroid receptor RXR and bind to the DR5 response element (Lam, Zhang et al.; 
Milbrandt 1988; Yoon and Lau 1993; Philips, Maira et al. 1997; Drouin, Maira et al. 
1998; Wansa, Harris et al. 2002).  As a functional assay to test the redox sensitivity of 
monomeric NGFI-B-dependent gene transcription, we used a previously described 
luciferase gene reporter construct (JA982/NBRE-luc) containing three contiguous NBRE 
sequences upstream of the luciferase gene (Katagiri, Hirata et al. 1997; Katagiri, Takeda 
et al. 2000).  PC12 cells were co-transfected with the NBRE-luc construct along with the 
renilla luciferase internal control (pRL-tk) to normalize for changes in transfection 
efficiency.  Both 100 µM and 200 µM hydrogen peroxide sharply induced NGFI-B-
dependent luciferase expression (Figure 3.3A).  Similarly, NBRE-luc expression was also 
induced by feeding cells the complex I substrates pyruvate/malate or the complex II 
substrate succinate in the presence of the complex III inhibitor antimycin, each of which 
drives complex III-dependent ROS production (Figure 3.3B) (Nemoto, Takeda et al. 
2000).  We next defined the impact of thiol reduction on NGFI-B-dependent transcription 
using the NBRE-luc / renilla-luc dual luciferase system to monitor gene transactivation in 
response to either heterologous NGFI-B-myc expression or endogenous NGFI-B 
induction.  DTT treatment of PC12 cells significantly inhibited NGFI-B-myc-dependent 
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luciferase expression compared to untreated NGFI-B-myc transfectants (Figure 3.4A).  
Similarly, DTT pretreatment also significantly decreased KCl-induced NGFI-B-driven 
luciferase expression (Figure 3.4B).  Since DTT had no effect on the capacity of KCl to 
induce NGFI-B protein (Fig. 3.2A), its inhibitory effect on endogenous NGFI-B-
dependent transactivation of the luciferase reporter suggests that NGFI-B transcriptional 
functions may be generally redox sensitive. To rule out the possibility that DTT was 
causing a global non-specific effect on transcriptional machinery, we assessed the 
capacity of DTT to inhibit cyclic AMP response element-driven reporter activity using a 
CRE-luc cAMP reporter (Salvemini, Mazzon et al.).  In PC12 cells expressing the CRE 
luciferase reporter and the renilla control, 20mM caffeine induced strong luciferase 
expression.  However, thirty minute pre-treatments with either 1 or 2mM DTT failed to 
inhibit CREB-dependent gene expression, arguing that the effect of DTT on NGFI-B-








Figure 3.3 Redox regulation of NGFI-B-mediated transcription 
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(A)  Dual luciferase assay (NBRE-luc reporter JA982) of NGFI-B dependent gene 
expression in PC12 cells alone (NT) or in response to treatments (8 hour) with 
KCl (50 mM, positive control) or hydrogen peroxide (100-200 μM). 
(B)  Dual luciferase assay (NBRE-luc reporter) of NGFI-B dependent gene expression 
in PC12 cells alone (NT) or in response to treatment (8 hour) with mitochondrial 
fuel substrates succinate (5 mM), pyruvate + malate (P/M, 2.5 mM), or hydrogen 
peroxide (200 μM). Results of luciferase activity in bar graphs are shown as 













Figure 3.4 Effects of DTT on NGFI-B-dependent transcription 
(A) Dual luciferase assay (NBRE-luc reporter) of the effects of DTT on NGFI-B-
dependent gene expression in PC12 cells expressing either empty vector (EV) or 
full length NGFI-B-myc and treated with DTT (2 mM, 8 hrs.). 
(B) Dual luciferase assay (NBRE-luc reporter) of the effects of DTT (2 mM, 30 min) 
on NGFI-B-dependent gene expression in PC12 cells alone (NT) or in response to 
8 hour treatment with the indicated concentrations of KCl. 
(C) Dual luciferase assay of the effects of DTT on caffeine-mediated, cyclic AMP 
response element reporter (CRE-luc reporter) activity in PC12 cells alone (NT) or 
in response to the indicated treatments with caffeine and DTT. Results of 
luciferase activity in bar graphs are shown as means ± SEM (n=3, * = p<0.05) 
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3.2.3 Hydrogen peroxide fails to block AMS alkylation of NGFI-B cysteines 
To begin to understand the mechanisms underlying the redox sensitivity of NGFI-
B function, a cysteine alkylation assay was performed using 4-acetamido-4′-
maleimidylstilbene-2,2′-disulfonic acid (AMS) that has been used to monitor cysteine 
oxidation in a variety of proteins, including Trx-2 (Hirasaka, Lago et al.).  AMS binds to 
free, reduced cysteine thiols and increases the size of protein targets per alkylation event 
by approximately 500 Daltons.  AMS binding is prevented if a reactive cysteine exists in 
any of various oxidized forms (disulfide bridges, hydroxylation, or glutathiolation, etc.).  
HEK-293T cells were transfected either with a mutant NGFI-B lacking the activation 
domain 1 (ΔAF-1-NGFI-B-myc) or Trx1-V5 (positive control) and were subsequently 
treated with 5mM DTT or various concentrations of hydrogen peroxide (ranging from 
500 µM – 5 mM) prior to TCA precipitation and lysis in the presence or absence of 
AMS.  Immunoblotting for Trx1-V5 revealed that AMS labeling occurred in the 
untreated (lane 2) and DTT-treated cells (lane 4), but not in hydrogen peroxide-treated 
cells (lane 3) (Figure 3.5A).  In contrast, no hydrogen peroxide-dependent blockade of 
AMS labeling was observed with ΔAF-1-NGFI-B-myc (Figure 3.5B).  Despite the 
presence of numerous cysteines, these data suggest that direct cysteine oxidation is not a 
mechanism of NGFI-B redox regulation.  These data leave open the possibility of indirect 
redox regulation of NGFI-B through redox control of phosphorylation cascades and/or 




Figure 3.5 Redox western blotting of Trx1 and ΔAF-1-NGFI-B 
Hek293T cells were transfected with Trx1-V5 (positive control) (A) or ΔAF-1-
NGFI-B-myc (B) and were either untreated (NT) or treated with hydrogen 
peroxide (30 min) at the indicated doses or DTT (5 mM, 30 min) followed by 
lysate labeling with AMS as indicated.  AMS bound to the upwardly shifted 
reduced (RED) but not peroxide-treated, oxidized (OX) forms of Trx1, but no 
oxidized non-AMS labeled species of ΔAF-1-NGFI-B-myc were detected. 
 
 72
3.2.4 Interaction of NGFI-B and Trx1 
Given the effects of chemically-mediated thiol reduction on NGFI-B expression 
and activity, we reasoned that NGFI-B function may be regulated by thioredoxin-1 
(Trx1), the most important and physiologically relevant cytoplasmic / nuclear thiol 
reducing enzyme system.  Full-length NGFI-B-myc and Trx1-V5 were co-transfected 
(equimolar) in Hek293T cells and lysates were subsequently immunoprecipitated with 
anti-V5 antibody and immunoblotted for anti-myc.  As shown in Figure 3.6A (lane 1), 
NGFI-B-myc was immunoprecipitated specifically by anti-V5 (Trx1-V5), but not by the 
negative control IgG (Fig. 3.6A, lane 2).  Interestingly, 30 minute pre-incubation of Trx1-
V5 and NGFI-B-myc expressing cells with hydrogen peroxide prior to cell lysis 
augmented the interactions compared to untreated cells (Fig. 3.6A, lane 3).  In contrast, 
DTT failed to affect the Trx1-V5:NGFI-B interaction  (Fig. 3.6A, lane 4).  To rule out 
that the Trx1:NGFI-B complex formed in co-transfected cells was not a result of 
overexpression, we also performed immunoprecipitation experiments with the 
endogenous proteins.  To induce NGFI-B protein, PC12 cells were stimulated with 
20mM caffeine.  Subsequently, lysates were immunoprecipitated with either an anti-
NGFI-B (M-210) antibody (sc5569) or IgG.  As shown in Figure 4B, anti-NGFI-B, but 
not IgG, immunoprecipitated endogenous Trx1, and this occurred only in cells where 






Figure 3.6 Complex formation between NGFI-B and Thioredoxin 1 
(A) Co-immunoprecipitation assays in Hek293T cells co-transfected with NGFI-B-
myc and Trx1-V5 and immunoprecipitated (IP) with either anti-Trx1-V5  or the 
negative control IgG (upper panel, lane 2) followed by immunoblotting (IB) as 
indicated (upper panel).  Cells were either untreated (NT) or treated with 
hydrogen peroxide (1 mM, 30 min) or DTT (2 mM, 30 min) as indicated prior to 
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lysis immunoblotting (IB) for NGFI-B-myc.  The lower two panels show input 
immunoblots for the heterologously expressed proteins. 
(B) Co-immunoprecipitation assays for endogenous NGFI-B and Trx1 interactions in 
PC12 cells alone (NT) or treated with caffeine (20 mM, 180 min) to induce 
NGFI-B prior to lysis.  Lysates were immunoprecipitated with either anti-NGFI-B 
(lanes 1, 3) or IgG (lane 2) followed by immunoblotting (IB) for Trx1 and NGFI-
B (upper two panels).  The lower panels show the levels of constitutive Trx1, and 
NGFI-B before and after induction with caffeine (Input). 
 
3.2.5 Mutational analysis of the NGFI-B/Trx1 complex  
A canonical view of Trx1 redox-regulatory action is that it binds proteins via its 
active site cysteines as a requisite step in thiol reduction.   We performed mutagenesis 
studies to characterize the mechanisms regulating the NGFI-B:Trx1 complex.  The NR4A 
family share 14 conserved cysteine residues spanning the DNA-binding (DBD) and 
ligand-binding domains (LBD), but share none in the activation domain. Co-
immunoprecipitation assays with full length Trx1-V5 and a mutant NGFI-B lacking the 
activation domain (ΔAF-1-NGFI-B-myc) revealed that the NGFI-B activation domain 
was dispensable for Trx1 binding (Figure 3.7A). However, after site-directed 
mutagenesis, we found that the active site cysteines (C32S, C35S) were absolutely required 
for NGFI-B-Trx1 binding (Fig. 3.7B, lanes 1-4).  These data are consistent with the 





Figure 3.7 Mutational analysis of the NGFI-B/Trx1 complex 
(A) Co-immunoprecipitation assays in Hek293T cells co-transfected with the ΔAF-1-
NGFI-B-myc truncation mutant and Trx1-V5 and immunoprecipitated (IP) with 
either anti-Trx1-V5  or the negative control IgG (upper panel, lane 2) followed by 
immunoblotting (IB) as indicated (upper panel).  Cells were either untreated (NT) 
or treated with hydrogen peroxide (1 mM, 30 min) or DTT (2 mM, 30 min) as 
indicated prior to lysis and immunoblotting (IB) for NGFI-B-myc. 
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(B) Co-immunoprecipitation assays in Hek293T cells co-transfected with the NGFI-
B-myc and the active site cysteine mutant Trx1-(C32S,C35S)-V5 were 
immunoprecipitated (IP) with either anti-Trx1-V5 or the negative control IgG 
(upper panel, lane 2) followed by immunoblotting (IB) as indicated (upper panel).  
Cells were either untreated (NT) or treated with hydrogen peroxide (1 mM, 30 
min) or DTT (2 mM, 30 min) as indicated prior to lysis immunoblotting (IB) for 
NGFI-B-myc. 
 
3.2.6 Trx1 inhibits NGFI-B-dependent transcription 
Finally, we tested the effects of Trx1 on NGFI-B function. PC12 cells were co-
transfected with the NBRE-luc and renilla-luc luciferase constructs in the presence or 
absence of NGFI-B-myc, Trx1-V5, and/or the active site mutant Trx1-V5, and luciferase 
transcriptional reporter assays were performed.  As expected, NGFI-B-myc alone induced 
strong luciferase expression (Figure 3.8A).  However, similar to the effects of DTT, 
Trx1-V5 sharply inhibited NGFI-B-dependent gene expression (Figure 3.8A).   In 
contrast, the active site mutant Trx1 failed to inhibit NGFI-B-dependent reporter activity 
(Figure 3.8A). Next we tested the physiologic relevancy of these observations by defining 
the role of transfected Trx1 in the regulation of endogenous NGFI-B function in PC12 
cells.   Cells treated with caffeine alone exhibited a strong induction of NGFI-B reporter 
activity (Figure 3.8B).  In contrast, caffeine-induced NGFI-B reporter activity was 
strongly decreased in the presence of wild type Trx1, but not mutant Trx1 (Figure 3.8B).  
Together, these results demonstrate that Trx1 is an inhibitor of NGFI-B-dependent, 






Figure 3.8 Effect of Trx1 on NGFI-B-dependent transcription 
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(A) Dual luciferase assay (NBRE-luc reporter JA982) of NGFI-B dependent gene 
expression in PC12 cells transfected with NGFI-B-myc along with either Trx1 or 
the active site mutant Trx1 (C32S, C35S) 
(B) Dual luciferase assay (NBRE-luc reporter JA982) of NGFI-B dependent gene 
expression in PC12 cells transfected with either Trx1 or the active site mutant 
Trx1 (C32S, C35S) and treated with caffeine to induce endogenous NGFI-B-
dependent transcription.   Results of luciferase activities are shown as means ± 















Illustration 7 Model of Trx1 regulated NGFI-B function 
Like other transcription factors, Trx1, may regulate NGFI-B-dependent gene expression 
through a direct interaction with NGFI-B. Using co-immunoprecipitation assays we 
clearly show that NGFI-B and Trx1 interact and that the active site of Trx1 is necessary 
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for the interaction between Trx1 and NGFI-B to occur, however, we were unable to prove 
using the thiol alkylating assay that NGFI-B contains any reactive cysteines.  While this 
does not rule out that a direct interaction could still be involved in the Trx1-dependent 
inhibition of NGFI-B transactivation it is necessary to uncover whether this interaction is 
direct through in vitro immunoprecipitation and whether NGFI-B can be directly 
modified by oxidants.  Another possible mechanism by which Trx1 inhibits NGFI-B-
dependent transcription is by binding and reducing another protein necessary for NGFI-B 
DNA binding and transcription.  The oxidized form of this unknown protein readily binds 
and promotes NGFI-B-dependent gene expression but it is possible that once reduced by 
Trx1 or addition of the chemical thiol reducing agent, DTT that a conformation change 
prevents the binding of this protein and NGFI-B, thus inhibiting gene expression by 
NGFI-B.   
 
3.3 DISCUSSION 
Apart from its tissue-specific functions in cell growth, differentiation, and death, 
NGFI-B and its closely related NR4A paralogous nuclear receptors have attracted 
considerable recent interest for their potential roles in metabolic signaling and disease 
(Pearen and Muscat).  The mechanisms coupling NGFI-B function to changes in 
metabolism are not well defined.  One potential route through which cellular and 
mitochondrial energy metabolism may signal in cells is through alterations in cellular 
redox balance by, for example, modulation of mitochondrial oxidant generation and shifts 
in the NAD+/NADH redox couple (McLaughlin, Strain-Damerell et al.). Here, we 
demonstrate that NGFI-B signaling is strongly sensitive to both oxidative and reductive 
changes in cellular redox balance, and regulated, at least in part, through the formation of 
a complex with the thiol reductase enzyme Trx1.  These studies indicate that the redox 
regulation of NGFI-B signaling occurs in a biologically redundant fashion to control both 
NR4A1 immediate early gene expression, and NGFI-B protein induction.    
NGFI-B was first identified roughly two decades ago by J. Milbrandt as a nerve 
growth factor-inducible homolog of the glucocorticoid (GC) receptor in PC12 cells 
(Milbrandt 1988; Mangelsdorf, Thummel et al. 1995). Like other nuclear receptors, 
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NGFI-B and its close NR4A family paralogs Nurr1 and Nor-1 contain a ligand 
independent AF-1 transactivation domain and a DNA binding domain with two 
contiguous zinc finger DNA binding motifs, along with a ligand-binding domain 
containing another ligand-independent AF-2 transactivation domain ((Paulsen, Weaver et 
al. 1992), Illustration 3).  Uniquely among nuclear receptors, NGFI-B and its closely 
related paralogs are classified as orphan nuclear receptors because no activating 
endogenous ligand has yet been identified for any member of the NR4A family.  
Moreover, the ligand-binding domain of NGFI-B has been confirmed by X-ray 
crystallography to lack the typical ligand docking pocket of other nuclear receptors, and 
instead contains exposed sterically bulky amino acid residues that exist in a closed 
confirmation (Wang, Benoit et al. 2003).  Together, these observations have led 
investigators to conclude that NR4A1 gene induction, post-translational modification, 
and NGFI-B localization are the major modes of NGFI-B regulation.  NGFI-B is an 
established substrate for multiple protein kinases and is post-translationally modified by 
complex patterns of phosphorylation on several amino acid residues in a stimulus-
dependent manner resulting in the regulation of NGFI-B localization within the cell 
(Fahrner, Carroll et al. 1990; Katagiri, Hirata et al. 1997; Katagiri, Takeda et al. 2000; 
Masuyama, Oishi et al. 2001; Jacobs, Boldingh et al. 2004; Han, Cao et al. 2006).  
Additionally, NGFI-B is among only a few transcription factors identified, including p53 
and DJ-1 / Park7 (Hao, Giasson et al.; Springer and Kahle; Mihara, Erster et al. 2003; 
Moll, Marchenko et al. 2006), that can be targeted to and regulate mitochondrial function 
(Li, Kolluri et al. 2000; Lin, Kolluri et al. 2004).  Whereas our data strongly support the 
notion that NGFI-B function is redox-sensitive, neither exogenous micromolar peroxide 
nor reduction with DTT or Trx1 influenced the average sub-cellular nuclear to 
cytoplasmic distribution of GFP-tagged NGFI-B in PC12 cells.  Future work will aim to 
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understand the sub-cellular distribution and spatiotemporal regulation of the NGFI-B / 
Trx1 redox-sensitive complex.   
To our knowledge, this is the first work that demonstrates the capacity for NGFI-
B and Trx1 to form a complex.  However, other members of the steroid / thyroid nuclear 
receptor superfamily have been shown to be redox regulated.  Recently it was reported 
that the GC receptor is redox-regulated by Trx1 (Makino, Yoshikawa et al. 1999).  
Unlike our results showing that DTT- and Trx1-dependent reduction of NGFI-B blocked 
its function, the transcriptional function of the GC receptor was inhibited by oxidative 
stress, and was restored in response to complex formation with Trx1 (Makino, 
Yoshikawa et al. 1999).  This divergent redox regulation of GC and NGFI-B receptors is 
consistent with their functional antagonism for the control of transcription in general 
(Philips, Maira et al. 1997).  Similarly, Trx1 has been shown to interact with and activate 
nuclear estrogen receptor alpha-dependent transcription (Hayashi, Hajiro-Nakanishi et al. 
1997).  Trx1 has also been demonstrated to activate transcription factors not belonging to 
the nuclear receptor family.  For example, Trx1 was found to increase p53-dependent 
transcription (Jayaraman, Murthy et al. 1997), to stimulate AP-1-driven transcription and 
DNA binding by forming a complex with Ref-1 (Hirota, Matsui et al. 1997), and to 
increase NF-κB-dependent transcription via a complex with the p50 subunit of NF-κB 
(Qin, Clore et al. 1995).  Our results showing that Trx1 and chemical reduction inhibited 
NGFI-B function (and induction) reveal a unique, inhibitory mechanism for Trx1 in 
transcriptional regulation. 
The work presented here reveals that NGFI-B function is sensitive to redox 
regulation upstream of NGFI-B itself (e.g. NGFI-B expression).  Trx1 contains a pair of 
vicinal cysteines in its active site (motif CVNVGC) that are required for its thiol 
reductase activity and typically for binding to substrates (Holmgren 1995; Weichsel, 
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Gasdaska et al. 1996).   We found using immunoprecipitation experiments in cells that 
indeed Trx1 interacted with NGFI-B in an active site cysteine-dependent manner. 
However, results showing that hydrogen peroxide failed to block NGFI-B labeling with 
the thiol alkylating reagent AMS suggest that cysteine reduction might not be the 
mechanism through which Trx1 operates.  Since Trx1 has also been shown to regulate 
protein nitrosylation (Wu, Parrott et al.), more work is needed to define the possible 
direct, biochemical mechanisms of Trx1-mediated NGFI-B regulation.   
Finally, these results provide a new biochemical framework to begin to address 
potential mechanisms linking NGFI-B and cellular redox changes to similarly pleiotropic 
physiological and pathological processes.  As reviewed by Maxwell et. al., (Nuclear 
Receptor Signaling, 2005), NGFI-B responds to diverse stimuli that are also associated 
with increased production of cellular ROS, including prostaglandins, phorbol esters, fatty 
acids, cell stress, mechanical agitation, mitogenic growth factors, and inflammatory 
cytokines.  Indeed, our observations that hydrogen peroxide alone could induce, and that 
DTT could inhibit, the induction of NGFI-B protein expression by caffeine, epidermal 
growth factor, and nerve growth factor confirms that the NR4A1 gene is likely to be 
broadly redox regulated. Though its physiologic functions are far from fully established, 
NGFI-B is involved in dopaminergic neuronal development, steroidogenesis, T-cell 
selection (apoptosis), and adipose development.  Arguably, the most important disease 
association for NGFI-B is atherosclerosis, which is strongly linked to oxidative stress and 
vascular remodeling involving circulating macrophages, and vessel wall endothelial and 
smooth muscle cells (Zafari, Ushio-Fukai et al. 1998).  In the vessel wall, NGFI-B 
activation is associated with pathologic vascular remodeling in response to tumor 
necrosis factor-1 alpha (TNF-α), in part by inducing the plasminogen activator-1 
activator (PAI-1) gene, ostensibly through an NGFI-B response element in the 5’ 
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upstream promoter region (Gruber, Hufnagl et al. 2003).  Similarly, TNF-α is well known 
to increase endothelial ROS production; and increased vascular oxidative stress and PAI-
1 levels each is associated with vascular disease risk (Li and Fukagawa).  Our results 
showing that NGFI-B is induced in vascular smooth muscle cells are consistent with 
other reports that NGFI-B induction occurs in response to smooth muscle cell 
proliferative stimuli.  Thus, reductive inhibition of NGFI-B in the vasculature may 
comprise a new therapeutic avenue for the prevention of neointimal formation, and 
plaque development during atherogenesis. 
   Together, these studies reveal an unappreciated role for NGFI-B as a mediator 
of a redox-sensitive pathway of gene regulation.  Moreover, the studies add NGFI-B to an 
expanding portfolio of potential substrates for Trx1, and shed light on a novel, inhibitory 
function of Trx1 in the regulation of gene expression.  This work lays the foundation for 
future work aimed at understanding in more detail the direct and indirect biochemical 




Chapter 4: NGFI-B regulates mitochondrial membrane potential 
(MMP) in L6 skeletal muscle cells 
4.1 INTRODUCTION 
  The involvement of nerve growth factor inducible protein B (NGFI-B) in the 
induction of cell death in a variety of cell lines is well established (Li, Kolluri et al. 2000; 
Holmes, Soprano et al. 2003; Kolluri, Bruey-Sedano et al. 2003; Holmes, Soprano et al. 
2004; Lin, Kolluri et al. 2004; Lee, Ma et al. 2005; Maddika, Mendoza et al. 2006).  It is 
now widely believed that NGFI-B induces apoptosis by localizing to the mitochondria 
through an interaction with Bcl-2 (Lin, Kolluri et al. 2004).  While various studies have 
demonstrated mitochondrial translocation of NGFI-B followed by the release of 
cytochrome c, and the induction of apoptosis, full understanding of the mechanism 
underlying NGFI-B-dependent programmed cell death is still undetermined.  An 
interaction between NGFI-B and Bcl-2 causes a conformational change in Bcl-2 that 
exposes its BH3 domain, but what events follow remain unclear.  One could speculate 
that the removal of Bcl-2 from inhibitory role of other pro-apoptotic Bcl-2 family 
members such a Bax, Bid, and Bak could allow for Bax oligomerization and 
permeabilization of the outer mitochondrial membrane, resulting in cytochrome c release 
(Kluck, Esposti et al. 1999).  However, researchers have not been able to demonstrate the 
intervening events that occur between the interaction between NGFI-B and Bcl-2, the 
subsequent conformational change, and the eventual release of cytochrome c.  Therefore, 
the manner in which this interaction causes the release of pro-apoptotic factors from the 
mitochondria continues to be purely conjecture.  The difficulty in uncovering answers to 
many of these questions is lies in the rapidity of apoptosis in general.  Once caspases are 
activated, distinction between cellular alterations that lead to apoptosis and those that 
simply result from caspase induction become complicated.   
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Correspondingly, studies have revealed that the irreversible loss of the MMP 
often precedes programmed cell death, but even this event is not observed in an all or 
none fashion (Cossarizza, Kalashnikova et al. 1994; Hishita, Tada-Oikawa et al. 2001; 
Karpinich, Tafani et al. 2002) leading to contradictory views concerning whether the 
MMP is actively involved in apoptosis or simply one of the many indicators that 
programmed cell death has been initiated.   
Temporary, reversible, loss of MMP appears to be involved in the regulation of 
intracellular calcium and could also be a means of regulating redox signaling within the 
cell.  Maintenance of the MMP at -180 to -200 mV in respiring mitochondria drives the 
influx of calcium ions (Ca2+) into the mitochondria (Rizzuto, Bernardi et al. 2000). This 
can create a sink for calcium and alter the availability of intracellular calcium for 
signaling purposes (Herrington, Park et al. 1996; Hoth, Fanger et al. 1997; Billups and 
Forsythe 2002).  An influx of too much calcium into the mitochondria is thought to 
induce apoptosis and lead to the full opening of the MPTP and irreversible loss of the 
MMP (Bossy-Wetzel, Newmeyer et al. 1998).  Lowered MMP also allows electrons to 
pass more efficiently through the ETC, thereby limiting the amount that slips to 
molecular oxygen and forming superoxide (Korshunov, Skulachev et al. 1997; Liu 1999).  
This can affect the redox poise within the cell and have an impact on redox signaling 
pathways.  The involvement of mitochondria in redox signaling has only been established 
in the last five years, but the redox state of the cell has been well established to have an 
impact on the induction of apoptosis.  Studies have not only correlated a rise in ROS to 
the induction of apoptosis, but directly linked increased ROS to the opening of the MPTP 
through oxidation of critical thiols on the matrix side of the adenine nucleotide 
transporter (ANT) (McStay, Clarke et al. 2002).  Researchers have also discovered that 
Bax requires a pro-oxidant environment in order to form the disulfide bridges necessary 
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for homo-oligomerization (Brustovetsky, Li et al.).  Previously we described evidence 
that NGFI-B induction and function are redox sensitive.  Along with the pro-apoptotic 
function of NGFI-B, this provides support for the involvement of redox regulation in 
NGFI-B-dependent cell death. 
Using the MMP-sensitive dye TMRM, we found that enforced NGFI-B 
expression in L6 skeletal myoblasts led to a significant loss of MMP that peaked 48hr 
after transfection.  Similarly, stable expression of NGFI-B in L6 muscle cells resulted in 
prolonged loss of the MMP without any signs of cell death.  The NGFI-B-induced 
decrease in MMP was specific to L6 myoblasts and was demonstrated using the MMP 
indicator tetramethylrhodamine methyl ester (TMRM).  In the absence of a pro-apoptotic 
stimulus, NGFI-B was evenly distributed between the cytoplasm and nucleus in cells 
lacking MMP.  NGFI-B expressing cells which lacked MMP were morphologically 
normal in comparison to their non-NGFI-B transfected neighbors displaying MMPs.  
Moreover, NGFI-B transfected cells had no increase in mitochondrial cytochrome C 
release 48hrs post-transfection.  Transfection of L6 skeletal muscle cells with a 
transactivation domain mutant NGFI-B (∆AF1-NGFI-B-myc) that is incapable of 
regulating gene transcription also led to a loss of MMP.  Interestingly, treatment of 
NGFI-B transfected cells with the calcium ionophore, ionomycin, 24 hours after 
transfection and prior to the loss of MMP led to a rapid loss of MMP within 3 hours, 
specifically in NGFI-B-transfected L6 cells.  Furthermore, oxygen consumption 
experiments on stable NGFI-B and empty vector (EV) L6 muscle cell lines revealed a 
significant increase in oxygen consumption nu NGFI-B L6 muscle cells only during State 
3 respiration, and no difference demonstrated during State 4 respiration.  Combined, 
these preliminary data suggest that NGFI-B-dependent loss of MMP in muscle cells may 
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involve mitochondrial calcium handling and provide a possible mechanism through 
which NGFI-B regulates mitochondrial function.    
4.2 RESULTS 
4.2.1 Overexpression of NGFI-B lowers mitochondrial membrane potential 
 Muscle cells become resistant to cell death upon differentiation (Wang and Walsh 
1996; Kamradt, Chen et al. 2002).  We hypothesized that this could provide an 
opportunity to study NGFI-B-depedent regulation of mitochondrial function.  L6 skeletal 
myoblasts, transfected with empty pEGFP vector or GFP-NGFI-B, were observed using 
fluorescent microscopy.  GFP-NGFI-B exhibits normal subcellular localization despite 
the size of the GFP tag (Katagiri, Takeda et al. 2000).  Non-treated (NT) GFP-NGFI-B 
transfected myoblasts demonstrated even distribution of GFP-NGFI-B throughout the cell 
while the pEGFP expressing cells expressed robustly within the cytosol (Figure 4.1A).  
The transfected cells were then stained with 25 nM TMRM and again observed by 
fluorescent microscopy.  At 48 hours post-transfection cells expressing GFP-NGFI-B 
appeared to have little to no TMRM fluorescence suggesting a loss or lowering of the 
MMP (Figure 4.1A).  These cells, however, remained morphologically similar to 
neighboring non-GFP-NGFI-B cells as well as those transfected with empty pEGFP 
displaying TMRM fluorescence (Figure 4.1A).  Quantification of 100 cells from each 
treatment group confirmed that NGFI-B-dependent loss of MMP was indeed significant 














Figure 4.1 Effect of NGFI-B on MMP in L6 myoblasts 
(A)  L6 myoblasts were transfected with either pEGFP or GFP-tagged NGFI-B.   
Cells overexpressing GFP-NGFI-B showed a significant loss of mitochondrial 
membrane potential indicated by the reduction in red fluorescence associated with 
the MMP dye, tetramethylrhodamine methyl ester (TMRM). 
(B) Quantification of the loss of TMRM. The * indicates significantly different from 
empty vector (p < 0.0001). 
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4.2.2 Overexpression of NGFI-B did not cause loss of MMP in HeLa cells 
 To assess whether this NGFI-B-dependent loss of MMP was unique to muscle 
cells, HeLa cells were transfected with either pEGFP or GFP-NGFI-B, and processed in 
the same way as previously described using TMRM staining.  Visualization using 
fluorescent microscopy followed by similar quantification revealed no significant 
difference in TMRM fluorescence between transfected and non-transfected as well as 
pEGFP and GFP-NGFI-B transfected cells, indicating that the loss of MMP resulting 
from over-expression of NGFI-B is unique to L6 skeletal myoblasts (Figure 4.2A).  
Again, quantification of TMRM fluorescence revealed no significant difference between 




















Figure 4.2 Effect of NGFI-B on MMP in HeLa Cells 
(A) HeLa cells 48 hours post transfection with either pEGFP or GFP tagged NGFIB 
demonstrated no significant difference in the presence of mitochondrial 
membrane potential. 





4.2.3 NGFI-B-dependent MMP loss is caspase-independent 
 To begin to understand the mechanism surrounding the observed NGFI-B-
dependent MMP loss in L6 myoblasts we first established, despite the healthy 
morphology associated with these cells lacking a MMP, whether apoptosis was 
occurring.  To do so, we initially treated L6 muscle cells with 50 µM of the pan-caspase 
inhibitor Z-VAD-FMK (BD Pharminogen) just after transfection with pEGFP or GFP-
NGFI-B.  The cells were treated with the same concentration of Z-VAD-FMK every day 
24 hours up to 48 hours to prevent the activation of caspases and the induction of 
apoptosis. Cells were then stained with TMRM to determine MMP using fluorescent 
microscopy.  Treatment with Z-VAD-FMK failed to prevent NGFI-B-dependent MMP 

























































4.2.4 Overexpression of NGFI-B does not cause excessive cytochrome c release 
 Aside from caspase activation, cytochrome c release from the mitochondria is 
another well-established indicator of apoptosis induction.  Therefore, in order to 
determine if cytochrome c release is associated with the NGFI-B-dependent loss of MMP 
in L6 muscle cells, myoblasts were transfected with empty vector, NGFI-B-myc, or Bax-
myc (positive control) for 48 hours.  Another set of L6 myoblasts were also exposed to 
DNA-damaging UVB to provide another positive control for cytochrome c release.  In 
each case some cytochrome c was released, however the amount released by both empty 
vector and NGFI-B-myc transfected cells was similar to that observed in non-transfected 
cells (Figure 4.4A).  Larger cytochrome c bands were observed in the cytosolic fractions 
from both positive controls, Bax transfected and UVB irradiated (Figure 4.4A).  
Densitometry of the bands using the GAPDH loading control further confirmed that 
cytochrome c released from the mitochondria in L6 cells expressing NGFI-B were 
minimal compared to the two well established inducers of apoptosis and cytochrome c 
















































































4.2.5 Loss of MMP is independent of the transcriptional function of NGFI-B 
 As a result of the even distribution of GFP-NGFI-B observed throughout the cell 
we next attempted to determine whether the transcriptional function of NGFI-B was 
important for the loss of MMP observed in NGFI-B expressing L6 muscle cells.  To do 
so, we utilized a construct containing a truncation of the NGFI-B activation domain 
(NGFI-BΔAF-1) (Figure 4.5A) that was therefore unable to drive NR4A family-
dependent transcription was utilized (Figure 4.5B).  L6 muscle cells were co-transfected 
for 48 hours with pEGFP and either empty pcDNA6/myc-his vector, myc-tagged NGFI-
B, or myc-tagged NGFI-BΔAF-1, in a 1:4 ratio.  Cells were then stained with TMRM and 
GFP positive cells were assessed for the presence of red fluorescence indicating MMP.  
Transfection with the myc-tagged NGFI-BΔAF-1 still lowered MMP (Figure 4.5C) 
suggesting the mechanism by which NGFI-B lowers MMP is independent of NGFI-B 
transcriptional function.  In fact, it appeared that the cells expressing the truncation 
mutant, NGFI-BΔAF-1, caused an even more robust loss of MMP at 48 hours than those 
transfected with full-length NGFI-B (Figure 4.5C).  This is consistent with observations 
from other labs indicating the ligand-binding domain (LBD) of NGFI-B is all that is 
sufficient for NGFI-B-dependent induction of apoptosis (Lin, Kolluri et al. 2004; Kolluri, 
Zhu et al. 2008).  Further investigation using a GFP-tagged form of the truncation 






















































































without the lipid-soluble calcium ionophore, ionomycin.  At concentrations of 1-10 µM, 
ionomycin has been shown to cause the release of calcium from several intracellular 
calcium stores, including the endoplasmic reticulum (ER) and the mitochondria (Brini, 
Bano et al. 2000).  Ionomycin along with phorbol 12-myristate 13-acetate (PMA) 
activates protein kinase C (PKC) and simulates T-cell receptor (TCR) mediated apoptosis 
(Weiss and Littman 1994).  Likewise, the induction of NGFI-B is also required for T-cell 
receptor (TCR) activation induced apoptosis (Cheng, Chan et al. 1997).  Interestingly 
researchers observed that treatment with cyclosporine A (CspA), an inhibitor of the 
MPTP component cyclophilin D, not only caused a reduction in the amount of NGFI-B 
protein induced by ionomycin but correspondingly prevented immature T-cells from 
undergoing apoptosis (Woronicz, Lina et al. 1995).  The involvement of the MPTP and a 
calcium ionophore in the regulation of TCR-mediated apoptosis provides evidence that 
mitochondrial calcium release could be involved in the regulation of NGFI-B-dependent 
loss of MMP in L6 myoblasts as well as in the induction of NGFI-B-dependent apoptosis 
in other cell lines.  Correspondingly, we observed that treatment with 1 µM ionomycin 24 
hours after transfection with GFP-NGFI-B caused a rapid, 3 hour, loss in MMP (Figure 
4.6A).  This same loss of MMP was not seen in cells transfected with pEGFP (EV) with 
or without treatment with ionomycin (Figure 4.6A).  Also, significant MMP loss was not 
observed at 24 hours in GFP-NGFI-B expressing L6 muscle cells (Figure 4.6A) 
providing preliminary evidence that calcium could be involved in the mechanism by 
which NGFI-B regulates the MMP.  Again, quantification of red fluorescence confirmed 










Figure 4.6 Role of calcium in NGFI-B-dependent MMP regulation 
(A) Twenty one hours post transfection with either pEGFP or GFP-NGFI-B L6 
muscle cells were treated with the vehicle control DMSO or with 1 μM 
ionomycin for 3 hours.  Cells were then stained with TMRM and their membrane 
potentials were assessed using fluorescent microscopy.  Ionomycin caused a 
significant loss of MMP in NGFI-B expressing cells compared to both the 
untreated NGFI-B and the ionomycin treated cells transfected with empty vector. 
(B) Quantification of the presence of TMRM. The * indicates significantly different 
from empty vector (p < 0.0001).  The ** indicates significantly different from 
untreated NGFI-B (p < 0.0001). 
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4.2.7 Stable expression of NGFI-B resulted in loss of MMP 
Next, L6 stable cell lines were created using the lentiviral system described in 
chapter 2 and either the FG9 empty vector (EV) or the FG9 construct expressing NGFI-B 
to further examine the mechanism responsible for this NGFI-B induced loss of MMP.  
Once single clones were selected using the antibiotic, hygromycin, and screened for the 
presence of either the EV or NGFI-B expression, cultures were continued under normal 
growth conditions to prevent experimental interference by the presence of hygromycin.  
Stable cell lines stained with both TMRM to observe MMP and Hoechst 33342 nuclear 
dye to allow for clear visualization of cell presence.  Remarkably, stable expression of 
NGFI-B in L6 myoblasts appeared to lower or cause the complete loss of MMP in all 
cells compared to those infected with EV (Figure 4.7A).  Consistent with this data, a 
similar experiment using flow cytometry also revealed a dramatic reduction in the 
presence of red fluorescence in NGFI-B stable L6 muscle cells compared to the EV stable 
L6 cell line (Figure 4.7B).  Interestingly, no sign of cell death or sickness appeared in the 
NGFI-B expressing stable cells which overall looked remarkably similar, 

























Figure 4.7 Effects of stable overexpression of NGFI-B on MMP 
(A) Using the lentiviral expression system, L6 muscle cells were infected with either 
NGFI-B or empty FG9 vector (EV) followed by selection in hygromycin.  Once 
colonies were screened for the stable expression of NGFIB, MMP was determined 
using TMRM and fluorescent imaging.  The Hoechst 33342 nuclear live cell stain 
(4 μM, Invitrogen) was utilized to clearly visualize NGFI-B expressing L6 cells 
lacking MMP as well as indicating that while lacking MMP the cells remain 
viable. 
(B) Flow cytometry was used to confirm the MMP effect witnessed during 
fluorescent imaging.  A definitive shift to the left of NGFI-B expressing L6 cells 
was observed compared to that of L6 cells infected with empty vector indicating 
stable expression of NGFI-B does indeed lower MMP. 
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4.2.8 Stable overexpression of NGFI-B does not alter mitochondrial number 
 Further characterization of the NGFI-B stable cell line used the membrane 
potential-independent mitochondrial dye, MitoTracker green (25 nM, Invitrogen).  Both 
fluorescent imaging and flow cytometry revealed no significant difference in 
mitochondrial mass (Figure 4.8A and B) as measured by MitoTracker green fluorescence.  
This suggests loss of MMP is not attributable to an overall decrease in mitochondrial 











Figure 4.8 Effects of stable overexpression of NGFI-B on mitochondrial number 
(A) Mitochondrial number was examined in both stable EV and NGFI-B 
expressing L6 cells using the membrane potential-independent mitochondrial 
dye, MitoTracker green.  No obvious difference in mitochondrial number was 
visualized using fluorescent microscopy.   
(B) Using flow cytometry the similarity in mitochondrial number between EV L6 
cells and NGFI-B L6 cells was confirmed.  Loss of MMP in NGFI-B- 





4.2.9 Stable overexpression of NGFI-B results in increased State 3 respiration 
 The stable cell lines were next tested for differences in oxygen consumption using 
a Clark-type electrode.  NGFI-B L6 stable myoblasts respired more robustly than EV L6 
muscle cells indicating an NGFI-B-dependent increase in normal State 3 respiration 
(Figure 4.9).  Oligomycin was then used to inhibit the ATP synthase in order to 
determine whether this difference in State 3 respiration was the result of an increase in 
proton leak.  No significant difference in State 4 respiration was observed, ruling out the 
involvement of proton leak through uncoupling proteins, the adenine nucleotide 
translocase (ANT), or flipping of protons across the lipid bi-layer.  Dinitrophenol (DNP) 
was used at the end of every sample to determine maximal respiration and check for 
overall cell fitness differences between the two stable cell lines.  Again no difference was 
observed upon the addition of DNP suggesting both cell lines were equally viable and 
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As muscle cells differentiate and fuse to form myotubes they not only become 
more resistant to cell death but exhibit changes in mitochondrial membrane potential 
(Wang and Walsh 1996; Kamradt, Chen et al. 2002). Using this knowledge and forced 
expression of NGFI-B in L6 skeletal muscle myoblasts we have begun to uncover the 
mechanism by which the nuclear hormone receptor NGFI-B regulates the MMP. We 
demonstrate that both transient and stable expression of NGFI-B in L6 myoblasts causes 
a remarkable reduction or loss of MMP without inducing cell death.  We did not observe 
any obvious localization of NGFI-B to the mitochondria, but rather diffuse expression 
throughout the cell.  However, experiments using a transcription-deficient mutant NGFI-
B still displayed lowered MMP after 48 hours.  We also reveal that stable overexpression 
of NGFI-B in L6 myoblasts causes a significant increase in State 3 but not State 4 
respiration, thus eliminating the possibility that the loss of MMP is a result of increased 
proton leak through proteins such as the ANT and UCP family.  Preliminary experiments 
utilizing the calcium ionophore, ionomycin do, however, reveal a possible role for 
calcium regulation in the mechanism by which NGFI-B lowers the MMP in skeletal 
muscle cells.  Further systematic experiments using inhibitors of the MPTP such as 
cyclosporine A and knock-down of Bcl-2 will hopefully illuminate how NGFI-B 
regulates membrane potential and possibly give further insight into how NGFI-B induces 
cell death. 
The mitochondrial targeting of the transcription factor NGFI-B through an 
interaction with the anti-apoptotic protein Bcl-2 has been shown to induce cell death in 
several cell lines (Li, Kolluri et al. 2000; Holmes, Soprano et al. 2003; Kolluri, Bruey-
Sedano et al. 2003; Holmes, Soprano et al. 2004; Lin, Kolluri et al. 2004; Lee, Ma et al. 
2005; Maddika, Mendoza et al. 2006).  Thus far, the only information about the 
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mechanism by which this interaction between NGFI-B and Bcl-2 propagates cell death is 
that it involves a conformational change in Bcl-2 which reveals its BH3-domain (Lin, 
Kolluri et al. 2004).  It is proposed that this converts Bcl-2 to a pro-apoptotic protein. 
Researchers assumed that this conversion does not cause apoptosis by resulting in direct 
action of Bcl-2 at the mitochondrial outer membrane but by rather through the decreased 
ability of Bcl-2 to inhibit the pro-apoptotic Bid and Bax.  Aside from the eventual release 
of cytochrome c following NGFI-B mitochondrial targeting through Bcl-2, the exact 
mechanism by which apoptosis is induced remains vague.  Interestingly, treatment of 
human neuroblastoma SK-N-SH cells and human esophageal squamous carcinoma 
EC109 and EC9706 cells with the retinoid-related molecule 6-(3-(1-adamantyl)-
4hydroxyphenyl)-2-naphthalene carboxylic acid (AHPN) caused NGFI-B translocation to 
the endoplasmic reticulum (ER) where it interacted with ER-localized Bcl-2, initiated the 
release of calcium, and lead to ER stress and eventual induction of apoptosis (Liang, Bin 
2007 Exp Cell Research).  The ER plays a critical role in the regulation of virtually all 
processes in healthy cells through maintenance of intracellular calcium and the folding 
and processing of newly synthesized membrane and secreted proteins (Berridge, Lipp et 
al. 2000).  Not surprising then, are the many studies which have demonstrated that 
disruption in the ER calcium pool is involved in the induction of ER stress and unfolded 
protein response (UPR) often leading to apoptosis (Bian, Hughes et al. 1997; Ferrari, 
Pinton et al. 2002).  Similar to the mystery surrounding how the NGFI-B:Bcl-2 complex 
leads to cytochrome c release it, likewise, remains unclear how the interaction between 
NGFI-B and Bcl-2 causes calcium release from the ER and subsequent ER stress.  Some 
studies suggest ER-targeted Bcl-2 inhibits apoptosis by preventing the efflux of calcium 
across the ER membrane (Scorrano, Oakes et al. 2003; Bassik, Scorrano et al. 2004; 
Palmer, Jin et al. 2004; Pinton and Rizzuto 2006). However, others suggest 
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overexpression of Bcl-2 actually causes an upregulation of ER calcium pumps and an 
increase in luminal calcium concentrations (Kuo, Kim et al. 1998). While further 
investigation of whether the same conformational change in Bcl-2 localized at the ER 
occurs upon interaction with NGFI-B and how this effects calcium release is needed, 
evidence presented thus far indicate a strong correlation between the interaction between 
NGFI-B and Bcl-2, calcium release, and the induction of apoptosis.   Understanding of 
how the NGFI-B: Bcl-2 complex regulates ER stress will no doubt provide insight into 
how that same interaction regulates NGFI-B-dependent mitochondrial induced apoptosis. 
 Mitochondria are also associated with intracellular calcium storage and 
regulation.  Maintenance of the MMP at 180-200 mV in respiring mitochondria drives the 
influx of calcium ions (Ca2+) into the mitochondria (Rizzuto, Bernardi et al. 2000). This 
creates a sink for calcium and alters the availability of intracellular calcium for signaling 
purposes (Herrington, Park et al. 1996; Hoth, Fanger et al. 1997; Billups and Forsythe 
2002).  Opposite of ER stress which is a result of an efflux of too much calcium from the 
ER, an influx of too much calcium into the mitochondria is believed to cause the full 
opening of the MPTP, irreversible loss of the MMP, and the induction of apoptosis 
(Bossy-Wetzel, Newmeyer et al. 1998).  We observed that treatment with 1 µM 
ionomycin 24 hours after transfection with GFP-NGFI-B caused a rapid, 3 hour, loss of 
MMP.  This same loss of MMP was not observed in non-treated GFP-NGFI-B 
transfected cells at 24 hours or in pEGFP transfected cells treated or left untreated.  At 
concentrations of 1-10 µM, ionomycin has been shown to cause the release of calcium 
from several intracellular calcium stores, including the endoplasmic reticulum (ER) and 
the mitochondria (Brini, Bano et al. 2000).  Ionomycin along with phorbol 12-myristate 
13-acetate (PMA) also activates protein kinase C (PKC) and simulates T-cell receptor 
mediated apoptosis (Weiss and Littman 1994).  Likewise, the induction of NGFI-B is 
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also required for T-cell receptor (TCR) activation induced apoptosis (Cheng, Chan et al. 
1997).  Interestingly researchers observed that treatment with cyclosporine A (CspA), an 
inhibitor of the MPTP protein, cyclophilin D not only caused a reduction in the amount of 
NGFI-B protein induced by ionomycin but correspondingly prevented immature T-cells 
from undergoing apoptosis (Woronicz, Lina et al. 1995).  The involvement of the MPTP, 
a calcium ionophore, and NGFI-B in the regulation of TCR-mediated apoptosis provides 
evidence that mitochondrial calcium release could be involved in the regulation of NGFI-
B-dependent loss of MMP in L6 myoblasts as well as in the induction of NGFI-B-
dependent apoptosis in other cell lines. 
Skeletal muscle is a highly metabolic tissue accounting for 50% of an organism’s 
energy expenditure and is considered the primary tissue for insulin-stimulated glucose 
uptake/disposal as well as paramount to the regulation of metabolism by managing 
circulating and stored lipids (Maxwell, Cleasby et al. 2005; Chao, Zhang et al. 2007).  
Consequently, muscle is now believed to be heavily involved in insulin sensitivity and 
other metabolic disorders.  Skeletal muscle mitochondria, being crucial to the regulation 
of fatty acid oxidation/storage and the generation of energy have now been directly 
linked to obesity and the onset of Type II diabetes (Simoneau, Veerkamp et al. 1999; 
Kelley, He et al. 2002).  Our research argues that NGFI-B overexpression can lead to the 
lowering or loss of MMP in skeletal muscle cells independent of cell death.  While this 
phenomenon may be attributed to established muscle cell resistance to cell death it still 
sheds light on the mechanism by which NGFI-B regulates both mitochondrial 
bioenergetics and apoptosis.  Previously, we have also demonstrated that NGFI-B 
induction and transcriptional activity is redox-regulated.  Lowering of the mitochondrial 
membrane potential has been shown to increase the flux of electrons through the ETC, 
therefore reducing the amount of electrons slipping to molecular oxygen and the 
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generation of superoxide (Korshunov, Skulachev et al. 1997; Liu 1999).  Therefore, 
NGFI-B-dependent MMP loss also provides a potentially unique method of regulating 
mitochondrial ROS production that could in turn regulate downstream redox targets such 
as NGFI-B, itself. A greater understanding of the correlation between mitochondrial 
bioenergetics and cell signaling pathways is critical to developing better treatments for 
the prevention of carcinogenesis, metabolic pathologies such as diabetes mellitus, as well 
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